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Temporal lobe epilepsy (TLE) is the 
most frequent type of focal drug-
resistant epilepsy. The purpose of 
this study was to investigate the 
results of TLE surgery and the com-
plications related to diagnostic and 
therapeutic procedures in a national 
epilepsy centre in Finland serving 
of a population of 4 million inhabit-
ants. The postoperative long-term 
seizure outcome and complications 
with adult TLE patients are compa-
rable to reported results from other 
established epilepsy centres interna-
tionally. 
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1  INTRODUCTION 
 
Epilepsies are one of the most common chronic neurological diseases, with a 
prevalence of 0.5 -1 % in the general population. It has been estimated that one third 
of newly diagnosed epilepsies will become refractory to medical therapy over time 
(Andermann 2002). Temporal lobe epilepsy (TLE) is the most frequent type of focal 
refractory epilepsy, accounting for two thirds of localisation-related epilepsies (Wieser 
and ILAE Commission on Neurosurgery of Epilepsy 2004). Surgical treatment of 
medically refractory epilepsy aims at reducing the number and intensity of seizures, 
minimising neurological morbidity and antiepileptic drug toxicity and finally, improving 
the patient’s quality of life. 
 
Preoperative evaluation in epilepsy surgery requires a multidisciplinary team 
approach including structural and molecular imaging, video-EEG monitoring, 
neuropsychological and psychiatric assessment. Recent advances in imaging 
technology, in particular, have enabled more patients to benefit from resective 
epilepsy surgery. In a randomised controlled trial the seizure outcome of epilepsy 
surgery in refractory TLE has been shown to be superior to prolonged medical 
therapy, and the patients in the surgical group also showed improvement in quality of 
life parameters (Wiebe et al. 2001). TLE patients with uncontrolled seizures are 
prone to sudden unexpected death in epilepsy (SUDEP), which is the most important 
epilepsy-related cause of death. Research during the past two to three decades has 
shown that incidence varies substantially depending on the epilepsy population 
studied, ranging from 0.09 per 1000 patient-years in newly diagnosed patients to 9 
per 1000 patient-years in candidates for epilepsy surgery (Tomson et al. 2008).  
Some studies have shown that the excess mortality associated with refractory 
epilepsy is eliminated in patients who are seizure-free after surgery (Sperling et al. 
2005), but these results are still controversial (Tomson et al. 2008). 
 
At Kuopio University Hospital, which serves as a Finnish national centre for epilepsy 
surgery referral for a population of 4 million inhabitants, systematic evaluation for and 
treatment with epilepsy surgery started in 1988.  Especially during the early years, 
the work concentrated mainly on surgery for TLE.  The main objective of this study 
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was to evaluate the experience of a single centre in preoperative work-up and long-
term seizure outcome in TLE patients from a defined geographical area. 
  3
2  REVIEW OF THE LITERATURE 
 
2.1  Definition and impact of temporal lobe epilepsy (TLE) 
 
According to definitions proposed by the International League Against Epilepsy 
(ILAE) and the International Bureau for Epilepsy (IBE), an epileptic seizure is a 
transient occurrence of signs and/or symptoms due to abnormal excessive or 
synchronous neuronal activity in the brain (Fisher et al. 2005). Epilepsy is a disorder 
of the brain characterised by 1) an enduring predisposition to generate epileptic 
seizures and by 2) the neurobiologic, cognitive, psychological, and social 
consequences of this condition. Epilepsy itself increases the risk of accidents and 
sudden unexpected death (SUDEP) (Tomson et al. 2008). 
 
The definition of epilepsy requires the occurrence of at least one non-provoked 
epileptic seizure. Epilepsy is not a specific disease or a single syndrome but rather a 
broad category of symptom complexes arising from disordered brain functions that 
themselves may be secondary to a variety of pathologic processes. In temporal lobe 
epilepsy (TLE), the most common syndrome of all epilepsies, the seizures originate 
from mesial and/or neocortical temporal lobe structures. 
 
2.2  Epidemiology of epilepsy and TLE 
 
In the Nordic countries the rates of prevalence for epilepsy vary from 3.6 to 5.3/1000 
in children and 5.5 to 6.3/1000 in adults (Keränen et al. 1989, Forsgren 1992, 
Eriksson and Koivikko 1997, Forsgren et al. 2005). Similar results have been 
reported in other European countries (Forsgren et al. 2005).  In 60 % of all cases the 
onset of the seizures is of focal origin. Of these focal epilepsies, in about 80% of the 
patients the seizures are initiated within the temporal lobes, which is the most 
epileptogenic region of the brain (Luby et al. 1995, Jeong et al. 1999).  
 
In epilepsy, three prognostic groups are generally considered: (1) spontaneous 
remission (20-30%) as seen, e.g. in benign epilepsy with centrotemporal spikes or 
childhood absences; (2) seizure remission achieved with antiepileptic drugs (AEDs) 
  4
(20-30%), which occurs in most focal epilepsies and juvenile myoclonic epilepsy 
syndromes; (3) persistent clinical seizures despite AEDs (30-40%), i.e. refractory 
epilepsy (Kwan and Sander 2004). It has been estimated that half of these patients 
with refractory epilepsy, making up about 5% of all epilepsy patients, would 
eventually benefit from epilepsy surgery (Engel 1993).  Of all epilepsy surgery 
procedures, TLE surgery has been performed most often.  
 
2.3  Subtypes of TLE 
2.3.1  Mesial temporal lobe epilepsy (MTLE) 
 
Mesial temporal lobe epilepsy (MTLE) is the most common localisation-related 
epilepsy in adults and is often associated with mesial temporal sclerosis (MTS). 
Mesial temporal sclerosis is characterised by segmental pyramidal cell loss in the 
CA1, CA3 and CA4 regions (Blumcke 2008). Onset of the seizures typically occurs in 
the latter half of the first decade of life, with increased incidence of complex partial 
seizures. The characteristic clinical semiology of the seizures is comprised of 
abdominal, autonomic or emotional auras. The lateralising clinical signs can be 
attributed to the typical spreading of seizures from mesial temporal structures with 
expression of, e.g. automatism, contralateral hand dystonia and postictal aphasia on 
the dominant-side speech functions (Lüders 2008).    
 
Apart from the most common pathology, hippocampal sclerosis, MTLE can be 
caused by other mesial pathologies like gliosis or tumours. The term ‘dual pathology’ 
is used in the presence of a neocortical lesion involving temporal or extratemporal 
areas (e.g. low-grade tumour or cortical dysplasia) and coexistent ipsi- or 
contralateral hippocampal sclerosis.  
 
2.3.2  Neocortical temporal lobe epilepsy (NTLE) 
 
The clinical semiology of neocortical or lateral temporal lobe epilepsy (NTLE) is more 
heterogeneous than in MTLE because the seizures can arise from many different 
and more widespread cortical foci. Visual and auditory hallucinations occur more 
commonly from discharges arising from the lateral temporal lobe than from the 
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mesio-basal temporal lobe. Consciousness may even be preserved, as in elementary 
seizures, or at least preserved for a longer time than in temporomesial seizures.  
 
The aetiology of NTLE consists of various possible pathologies including, e.g 
malformation of developmental origin, vascular or neoplastic lesions. Due to the 
development of the MRI techniques, focal cortical dysplasias (FCD) are increasingly 
diagnosed as a cause of focal epilepsy and are thus identified in about one fourth of 
the operated patients (Tassi et al. 2002). In their series of 120 patients with cortical 
dysplasias, Fauser et al. found 55 patients with FCD localization in the temporal lobe. 
In addition, they described 48 out of 55 of their TLE patients as being assoaciated 
with dual pathology (i.e. FCD located in the temporal lobe or temporo-occipitally and 
additional hippocampal sclerosis) (Fauser et al. 2006). In 2004 Palmini et al. 
proposed the now widely used classification of the cortical dysplasias for clinical and 
research purposes; mild malformation of cortical development (MCD) with ectopically 
placed neurons in or adjacent to cortical layer I are classified as type I and 
microscopic neuronal heterotopia outside layer I as type II. These cannot be detected 
by current MRI techniques. Focal cortical dysplasias (FCD) were classified according 
to whether there are only architectural abnormalities of the cortical layer (FCD type 
Ia: cortical dyslamination or type Ib: cortical dyslamination with giant or immature 
neurons) or whether, in addition to architectural abnormalities, they appear with 
dysmorphic neurons or balloon cells (FCD Taylor type IIa: dysmorphic neurons but 
without balloon cells or IIb: dysmorphic neurons and balloon cells) (Palmini et al. 
2004).  
 
Dysplastic tumours such as dysembryoplastic neuroepithelial tumours (DNET) and 
gangliogliomas are a common pathology associated with focal epilepsies and from 
the oncological standpoint are considered to be benign lesions. Sharma et al. 
reported thirty two patients with operated DNETs, the majority of them (94%) located 
in the temporal lobe (Sharma et al. 2009).  According to the recent report of Ruban et 
al. with 38 patients, gangliogliomas are the most frequent tumours occurring in TLE, 
followed by DNETs (Ruban et al. 2009). Both gangliogliomas and DNETs are 
frequently associated with focal cortical dysplasia (50% and 83%, respectively), 
which may require rather radical resection of the pathological area to achieve a good 
seizure control (Prayson et al. 1995, Takahashi et al. 2005). Low-grade tumours of 
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glial origin (pilocytic astrocytoma, grade I-II astrocytomas and olidendrogliomas) and 
cavernous hemangiomas are also a recognized pathological entity related to chronic 
TLE.     
 
2.4  The course of TLE 
 
TLE patients have an increased incidence of family history of epilepsy, suggesting a 
genetic predisposition (Currie et al. 1971, Helbig et al.2008). After a presumed initial 
insult, such as prolonged complex febrile convulsions, status epilepticus, CNS 
infection or trauma, TLE patients may initially have a long seizure-free interval or 
latency period of years before the unprovoked recurrent seizures develop (French et 
al. 1993). In TLE habitual seizures usually begin during the first 10-15 years of life 
(French et al. 1993, Engel 1996).  
 
The drug of choice for the first-line monotherapy in TLE is carbamazepine or 
oxcarbazepine. Other monotherapy options are lamotrigine, levetiracetam, valproate 
and topiramate. Moreover, there are currently over 20 AEDs that can be used in 
different combinations. Some patients reach complete remission of seizures after the 
antiepileptic treatment has been started. Other patients who develop intractable TLE 
have a seizure-free interval initially. However, seizures may recur during 
adolescence or later; and often they then become intractable (Engel 1996). There are 
also patients with intractable epilepsy who have an evolutionary pattern of TLE, with 
seizures becoming progressively more elaborate over time (French et al. 1993). Of 
all TLE patients treated with antiepileptic medication, 60 to 70% are not satisfactorily 
controlled (Currie et al. 1971, Lindsay et al. 1979). If temporal lobe seizures persist, 
the disorder may lead to neuronal damage (Salmenperä et al. 2001)  followed by 
impaired cognitive performance and behavioural disturbances (Oyegbile et al. 2004). 
Therefore, when the clinical situation of TLE points to a progression of the disorder, 
despite appropriate antiepileptic medication, the patient should be evaluated for 
resective surgical treatment. In particular, in TLE associated with hippocampal 
sclerosis, early surgery should be considered because seizures are almost always 
refractory (Semah et al. 1998) and surgery has been proven to be highly effective.  
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2.5  Temporal lobe epilepsy surgery 
2.5.1  History of epilepsy surgery 
 
The history of epilepsy surgery is presumed have begun in 1886 in London, when 
Victor Horsley operated a 22-year-old man with focal motor seizures caused by a 
depressed skull fracture (Horsley 1886). Thereafter, there was significant interest in 
surgical treatment by removing probable epileptogenic lesions, partly due to the fact 
that no effective antiepileptic drugs were available before the introduction of 
phenobarbital in 1912. After the first human EEG was introduced by Berger, the 
understanding and diagnostics of epilepsy was revolutionised (Berger 1929). In 
particular, this helped researchers to discover the role of the temporal lobe as an 
important localisation of pharmaco-resistant epilepsy. The pioneer work of Jasper 
and Penfield in Montreal and Bailey and Gibbs in Boston introduced the anterior 
temporal lobe (ATL) resection (Jasper and Kershmann 1941, Penfield and Flanigin 
1950, Bailey and Gibbs 1951). Murray Falconer from the UK introduced a standard 
en-bloc ATL resection, which routinely included removal of the temporomesial 
structures (Falconer 1953). His work profoundly influenced our understanding of the 
role of hippocampal sclerosis in the pathogenesis of mesial temporal lobe epilepsy 
(MTLE) (Falconer and Taylor 1968).    
 
2.5.2  Indications for epilepsy surgery candidacy 
 
First, the seizures need to be drug-refractory. Recently, drug-refractory epilepsy has 
been defined as the failure of adequate trials of two tolerated and appropriately 
chosen and used AED schedules (whether as monotherapies or in combination) to 
achieve sustained freedom from seizures (Kwan and Sperling 2009). Patients with 
refractory epilepsy should be referred to epilepsy centres for comprehensive 
evaluation and presurgical work-up. Second, the informed patient must declare his 
wish to undergo presurgical evaluation. Third, for the resective approach, the clinical 
diagnosis must be focal epilepsy.  
 
Alhough higher age (over 50 years) is not a contraindication for TLE surgery, it has 
been shown in several reports that seizure outcome is more favourable in younger 
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patients (Sirven et al. 2000, Boling et al. 2001, Grivas et al. 2006). For older patients 
the risks for surgical and neurological complications are, as expected, somewhat 
higher than in series of younger patients (Rydenhag and Silander 2001, Grivas et al. 
2006).   
 
Whereas normal intelligence is not a prequisite for surgical consideration, cognitive 
deficit raises the possibility of multifocal and multilobar epileptogenicity. However, it 
has been shown that patients with low IQ can benefit from epilepsy surgery, in 
particular, with lesional TLE, although the seizure outcome at the lowest IQ level was 
not found to be as satisfactory. In this latter group of patients, in order to make final 
recommendations, the cognitive effects of epilepsy surgery and psychosocial 
outcome should be studied further in details (Malmgren et al. 2008).  
 
Patients with chronic psychiatric diseases are usually not excluded from surgical 
evaluation, but preoperative counselling with a psychiatrist familiar with epilepsy 
surgery is mandatory. However, patients with active psychosis, depression or a 
significant personality disorder would preclude surgery because of the inability of the 
patient to cooperate in the evaluation and difficulty in post-operative rehabilitation. 
Cardiorespiratory diseases, coagulopathies and other internal risk factors may 
require further preoperative consultation, particularly with older patients, and may 
consequently prevent surgical intervention. 
 
2.5.3  Preoperative evaluation 
 
A general aim of the presurgical evaluation in TLE is to verify unifocal ictal onset of 
habitual seizures with video-EEG monitoring, which should also be in concordance 
with clinical seizure semiology and not contradict a possible focal lesion detected by 
high resolution MRI. Neuropsychological testing, molecular imaging and 
magnetoencephalography (MEG) are additional tools for localising the seizure onset 
zone. In cases of non-lesional TLE or dual pathology, further evaluation with 
intracranial EEG electrodes is usually warranted (Figure 1). 
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Patient history 
Neurological examination 
Seizure semiology 
Interictal EEG 
High-resolution MRI 
Scalp EEG-videotelemetry 
Neuropsychological evaluation 
Psychiatric examination 
PET /
Interictal or ictal SPECT /
MEG 
Nonconclusive or discocordant 
results in non-invasive evaluation 
 
Concordant non-invasive results 
WADA test  
(before or after invasive 
electrodes) 
 
WADA test 
Evaluation with intracranial 
electrodes 
(Subdural strips, grid, depth 
electrodes) 
Resective surgery 
Tailored temporal lobe resection 
including 
amygdalohippocampectomy 
(Ecog) 
Selective 
amygdlohippocampectomy 
Only lesionectomy 
No indication of resective 
surgery 
 
Optimizing AED-therapy 
VNS 
Re-evaluation, if new evidence of 
focal findings (e.g. 3T MRI) 
 
 
Figure1. The scheme for preoperative evaluation in TLE 
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2.5.3.1  Noninvasive evaluations 
 
2.5.3.1.1  Seizure semiology and neurological examination 
 
The clinical history of the patient with regard to, e.g. seizure semiology, past history 
of medication, family history and his/her neurological examinations, are the clinical 
basis for further preoperative evaluation. Careful analysis of the clinical 
manifestations allows a hypothesis to be made as to the localisation and 
lateralisation of the epileptogenic zone. This hypothesis will require the support of 
other tests; the epileptogenic zone cannot be localised by seizure semiology alone. 
 
2.5.3.1.2  Scalp (surface) EEG 
 
Interictal EEG provides information about the irritative zone of the epileptogenic 
areas but is never alone sufficient for localisation of the epileptogenic zone for 
surgical treatment, since the interictal EEG abnormalities seen in a significant 
proportion of TLE patients are often multilobar or bilateral.  
 
Ictal scalp EEG with simultaneous video recording (video-EEG monitoring) of the 
typical seizures of a given patient is a mainstay for defining the exact type and origin 
of the seizure in order to proceed to resective surgery. To increase the possibility for 
ictal recordings, antiepileptic medication is significantly reduced or even withdrawn 
during video-EEG. Additional semi-invasive sphenoidal or foramen ovale electrodes 
may be helpful for localising and lateraling the epileptic focus in TLE (Velasco et al. 
2006, Guangming et al. 2009). In a majority of adult patients with TLE, surface ictal 
EEG combined with other non-invasive methods provides accurate estimation of the 
epileptogenic zone for clinical decision-making for surgery (Kilpatrick et al. 1997, 
Foldvary et al. 2001). 
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2.5.3.1.3  Magnetic resonance imaging (MRI) 
 
2.5.3.1.3.1  Structural imaging 
 
The development of magnetic resonance imaging (MRI) has played the most 
important role in selection of patients for surgical treatment of epilepsy. To 
demonstrate structural lesions associated with TLE, MRI provides the best 
anatomical detail of any imaging modality. It is highly sensitive and specific in 
detecting mesial temporal lobe sclerosis (MTS), which is the most frequent structural 
abnormality observed in TLE (Duncan 1997).  Typical features of MTS are 
hippocampal atrophy, loss of internal architecture, increased signal in T2-weighted 
images and decreased signal in T1-weighted images (Figure 2). Other commonly 
seen pathologic conditions related to the aetiology of TLE are malformations in 
cortical development (cortical dysplasias), low-grade astrocytic tumours, 
developmental tumours (e.g. ganglioglioma, dysembryoplastic neuroepithelial tumour 
(DNET) and vascular malformations.  
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Figure 2.  Typical imaging findings in hippocampal sclerosis. A 41-year-old woman 
with a 23-year history of TLE. Three Tesla MRI reveals a right-sided hippocampal 
sclerosis (white arrow) and the seizure onset is from the right temporal lobe 
according to the ictal EEG recording (Axial and coronal T2 images, A-B). FDG-PET 
image is fused with MR-imaging and it shows wide hypometabolism in right 
temporomesial and temporal neocortical areas (C-D).   
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High resolution MRI (i.e., 1.5 to 3T or more) is usually performed according to a 
specific imaging protocol, which is tailored to evaluate the pathological conditions 
commonly seen in drug-resistant TLE patients. Transaxial T2- weighted fast spin 
echo imaging with 3-5 mm thick sections covers the whole brain and is used for 
efficient screening of any space-occupying lesion. Coronal T2- weighted fast spin 
echo images are necessary for precise anatomic localisation within the temporal lobe 
and are mandatory for adequate evaluation of MTS. A coronal or sagittal three-
dimensional (3D) T1- weighted gradient echo volume aquisition with isotropic voxels 
covers the whole brain with 1.2- 2 mm partitions, allows  reformatting in any 
orientation and  enables estimation of hippocampal volumetry. Fluid attenuated 
inversion recovery sequence (FLAIR) is also induced in the protocol, usually in both 
transaxial and coronal orientations and preferably with rather thin slices. Inversion 
recovery (IR) sequence provides a good contrast between the gray and white matter, 
and double inversion recovery (DIR) sequence has been reported to increase 
detection of subtle alterations in gray matter (Rugg-Gunn et al. 2006). T2*-weighted 
or susceptibility-weighted sequences may be used to detect traces of hemosiderin in, 
for example, cavernomas or after trauma. The coronal sequences are best oriented 
at a right angle to the long axis of the hippocampus. Such studies are monitored by 
an experienced neuroradiologist, and contrast material is administered for further 
characterisation only if a space-occupying lesion (tumour or cavernoma) is identified.  
 
Patients with no evident lesion on MRI, despite conventional epilepsy imaging 
protocol, remain a challenging subgroup of TLE patients. Development of 3T MRI 
techniques can improve the presurgical evaluation of patients with focal epilepsy who 
were previously considered MRI negative with 1.5 T MRI (Knake et al. 2005) (Figure 
3). Strandberg et al. showed that MRI at 3T could identify abnormalities in 20 % of 
patients with previously unremarkable pathology, above all, malformations of cortical 
development (MCD) (Strandberg et al. 2008).  Recently, encouraging results have 
been reported on statistical methods, such as statistical parametric mapping, which 
allows comparisons of individual 3D imaging data to a group of healthy control 
individuals and may increase the sensitivity of interpretation (Rugg-Gunn et al. 2006). 
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Figure 3. Preoperative multimodal evaluation. A 31-year-old female with partial 
epilepsy since the age of four and nowadays having seizures almost daily. 
Preoperative MRI with 1.5 Tesla did not show any abnormalities, but imaging with the 
3 Tesla MRI revealed blurring of the white matter in the right upper temporal gyrus 
(arrow) (T1 coronal image) indicating possible focal cortical dysplasia (A). The MEG 
study detected interictal spikes at the same localisation (B) and FDG-PET showed 
hypometabolism in the lateral temporal cortical area (arrow) (C). The area of ictal 
onset was localised to contacts 3, 4, 12, 14 and 15 with subdurally implanted GRID- 
electrode (D) and the neocortical resection of temporal lobe tailored according to the 
ictal intracranial EEG-findings was performed in November 2009 (Arrow indicates the 
site of cortical dysplasia). The patient was seizure-free (Engel 1A) at the three 
months follow-up, and the pathological examination confirmed focal cortical dysplasia 
(Taylor type IIB). The postoperative MRI (T2 coronal image) showed the resection of 
temporal lateral cortex including the cortical dysplasia (E).    
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Diffusion tensor imaging (DTI) is a relatively new technique, which provides three-
dimensional information about water diffusion in tissues. It is sensitive to the 
molecular movement of water, which indicates cellular integrity and pathology. Some 
reports have shown that DTI could help to localise epileptogenic areas in patients 
with refractory epilepsy but whose results with conventional MRI are normal (Rugg-
Gunn et al. 2001, Thivard et al. 2006, Chen et al. 2008).  
 
2.5.3.1.3.2  Magnetic Resonance Spectroscopy 
 
Magnetic resonance spectroscopy is the only non-invasive method of measuring 
metabolites in brain tissue in vivo. Proton magnetic resonance spectroscopy (1H-
MRS) can detect a decrease of N-acetyl aspartate (NAA) and unilateral presence of 
a lactate (Lac) peak in mesial temporal lobe structures, thus lateralising the 
epileptogenic focus (Chernov et al. 2009). The role of spectroscopy in clinical workup 
remains controversial, because the reported results are based on retrospective 
series with a small number of patients. 
 
2.5.3.1.3.3  Functional MRI (fMRI) 
 
Functional MRI (fMRI) provides non-invasive measurements of neural activity by 
means of a signal dependent on the oxygen level in the blood, which is well-
established in evaluation of motor functions. Delineation of the primary motor areas 
does not play an important role in TLE, but fMRI has been used to define language 
dominance and to predict possible memory decline after temporal lobe resection 
(Binder et al. 2008, Powell et al. 2008). Studies comparing the correlation between 
the Wada test and fMRI in determination of language dominance still provide only 
cautious recommendations for replacing the Wada test with non-invasive fMRI, 
particularly in left-sided temporal or extratemporal epilepsy or in cases of mixed 
speech dominance (Woermann et al. 2003, Benke et al. 2006, Arora et al. 2009). 
 
 
 
  16
2.5.3.1.3.4  Volumetry  
 
MRI-based hippocampal volumetry has been used for quantitative identification of 
uni- or bilateral hippocampal damage, which could be missed by visual inspection. 
The hippocampal volumes have usually been measured manually, but a method for 
using estimations of hippocampal grey matter content, an automated MRI analysis of 
hippocampal atrophy, is under development (Bonilha et al. 2009). Hippocampal T2 
time also reflects the pathology of the tissue. As water content is often higher in 
tissue with a pathological change than in the surrounding normal tissue, the change 
results in longer T2 relaxation time. Van Paesschen et al. (1997) found a positive 
correlation between hippocampal T2 time and the ratio of glial to neuronal density in 
the hippocampus of TLE patients. Moreover, prolongation of hippocampal T2 time 
correlated with the severity of loss of hippocampal volume in TLE (Van Paesschen et 
al. 1995, Pitkänen et al. 1996, Van Paesschen et al. 1997). Both volumetry and T2-
relaxometry are, however, currently used more in research than in individual 
preoperative evaluations. 
 
2.5.3.1.4  Molecular imaging 
 
2.5.3.1.4.1  Positron Emission Tomography, PET 
 
Positron emission tomography (PET) is widely used as an additional diagnostic tool 
for defining the epileptogenic areas of the brain. Interictal (rarely ictal) 18F-
fluorodeoxyglucose PET ([18F]FDG-PET) is the method most commonly used to 
visualize the glucose metabolism of the brain, which is often characterized by 
regional reduction in glucose uptake (interictal hypometabolism) (Figure 2). Other 
PET tracers have also been developed during recent years to visualise a wide variety 
of specific receptor systems: [11C]flumazenil PET for GABA-receptors, 
[11C]carfentanil PET for opioid receptors, [18F-FCWAY] PET (selective 5-HT1A 
receptor antagonist) for serotonin receptors and AMT (α-[11C]methyl-L-tryptophan) 
PET for imaging the synthesis of serotonin. The lack of larger clinical studies has 
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limited the use of these receptors over [18F]FDG-PET imaging in epilepsy (Goffin et 
al. 2008).  
 
A recent meta-analysis by Willman et al. showed that ipsilateral [18F]FDG-PET 
hypometabolism may be an indicator for good postoperative outcome. Moreover, if 
the ictal scalp EEG and MRI are concordant, the PET does not appear to be 
necessary (Willmann et al. 2007). On the other hand, if the MRI and scalp-EEG 
results are nonlocalising, it has been shown that the PET is also cost-effective in 
presurgical evaluation (O'Brien et al. 2008).   
 
2.5.3.1.4.2  Single Photon Emission Computed Tomography, SPECT 
 
Single photon emission computed tomography (SPECT) is a non-invasive method for 
estimating the regional flow of blood in the brain ictally or interictally. It is used as 
commonly as PET studies as an additional diagnostic aid in localizing the zone of 
seizure onset.  99mTc-labeled compounds are generally used to show acute ictal 
hyperperfusion of the seizure-onset zone (or interictal hypoperfusion), such as 99mTc-
ethyl cysteinate dimer (ECD) or 99mTc-hexamethylpropyleneamine oxime (HMPAO). 
[123I]Iomazenil or [123I]NNC-13-8241 has been used for benzodiazepine receptor 
studies. 
 
In temporal lobe epilepsy, the superiority of ictal SPECT studies compared to 
interictal studies has been clearly shown, indicating sensitivities of 84-97% for ictal 
SPECT studies but only 44-55% for interictal SPECT with regard to the localisation of 
seizure origin (Devous et al. 1998, Zaknun et al. 2008). Injection of the tracer as early 
as possible during the seizure is extremely important, since the switch from ictal 
hyperperfusion to postictal hypoperfusion and the propagation of the seizure may 
confuse interpretation of the ictal onset zone (Van Paesschen 2004). Digital 
subtraction of ictal and interictal SPECT scans co-registered with MRI (SISCOM) is a 
technique that combines structural and functional imaging, thus improving delineation 
of the epileptogenic zone. The predictive value of SISCOM with respect to good 
surgical outcome has also been shown (O'Brien et al. 1998, Matsuda et al. 2009).  
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2.5.3.1.5  Magnetoencephalography, MEG 
 
Magnetoencephalography (MEG) is a non-invasive method of defining the cortical 
seizure focus based on localisation of magnetic dipoles, indicating synchronous 
electrical activity of a larger number of cells (Figure 3). It has also been used to 
localise the eloquent cortical functions near the epileptogenic focus and to determine 
the language dominant hemisphere (Papanicolaou et al. 1999, Hirata et al. 2004). It 
has been shown that MEG can detect interictal spikes more precisely than video-
EEG does (Knake et al. 2006); but on the other hand, to obtain ictal recording by 
MEG is limited and technically is very demanding. Analysis of the MEG source 
analysis can provide additional information for localising the seizure onset zone in 
temporal lobe epilepsy, for predicting the outcome and possibly for planning limited 
surgical resections (Assaf et al. 2004). Due to the relatively high cost of MEG 
installation, it is available in only a few epilepsy surgery centres. Thus far the only 
MEG establishment in Finland was launched in Helsinki in 1994 (BioMag Laboratory, 
Helsinki, Finland), providing presurgical localisation of the eloquent cortex and 
epileptic foci. 
 
2.5.3.1.6  Neuropsychological evaluation 
 
Neuropsychological assessment in TLE plays a pivotal role both in preoperative 
evaluation and in post-operative follow-up. Comprehensive evaluation of cognitive 
functioning associated with frontal-lobe functions includes, e.g intelligence, attention, 
language, visuospatial and frontal ‘executive’ skills. The learning and memory 
dysfunction associated with TLE is well recognized and may provide useful 
information about the localisation and lateralisation of the epileptogenic area (Jones-
Gotman et al. 2000). In the dominant temporal lobe, the deficits typically involve 
verbal memory and word-retrieval skills; and in the nondominant lobe, impairments 
on measures of visuospatial functioning and visual memory are recognized, but the 
neuropsychological test for the latter provides less accuracy mainly due to the lack of 
adequate test methods. It has been shown that presurgical neuropsychological 
evaluation is a useful tool for predicting the patient’s postoperative cognitive outcome 
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and even the seizure outcome (Stroup et al. 2003, Baxendale et al. 2006, Potter et 
al. 2009). 
 
The classical WADA (intracarotid amobarbital test, IAT) test was first introduced 1960 
in order to lateralise the speech dominance by injecting sodium amobarbital into each 
carotid artery (Wada 1949, Wada and Rasmussen 1960). Assessment of memory 
function in the WADA test, which is based on the hypothesis that pharmacologic 
inactivation of a single temporal lobe should not create global amnesia if the awake 
temporal lobe is healthy, was first reported by Brenda Milner (Milner et al. 1962, 
Milner 1997). There is currently a large discrepancy between epilepsy surgery 
centres in how they use the Wada test for presurgical evaluation of TLE patients. The 
large study of Haag et al. examined 1421 Wada procedures with regard to its role in 
presurgical evaluation conducted in 16 European centres between the years 2000 
and 2006. The overall frequency of the Wada test compared to the number of 
surgeries was 38%, varying among centres from 8% to 110% (including re-evaluation 
of some patients); and the number of Wada tests performed at centres has been 
decreasing since 2000. The reliability and validity of language determination was 
rated as good but its prognostic value in memory decline was questioned (Haag et al. 
2008). In an international survey (92 epilepsy surgery centres in 31 countries) by 
Baxendale et al. only 12 % of the centres indicated that every candidate for TLE 
surgery should undergo a Wada test prior to surgery, and one-third of the centres 
never or very rarely (in less than 5% of cases) performed a Wada procedure 
(Baxendale et al. 2008). The emerging functional MRI paradigms in preoperative 
evaluation of language dominance and verbal memory may further reduce the role of 
Wada test in coming years.  
 
2.5.3.2  Invasive EEG evaluation 
 
2.5.3.2.1  Indications  
 
In the majority of TLE cases, the patients have MR imaging that suggests unilateral 
mesial temporal sclerosis and concordant interictal and ictal scalp-EEG recordings, 
functional imaging and clinical findings, hence allowing straightforward surgical 
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treatment.  When non-invasive studies remain non-concordant or inconclusive with 
regard to localisation of seizure onset zone, video-EEG with intracranial EEG 
electrodes is warranted. In general, the indications for invasive EEG evaluation in 
TLE are: non-lesional focal epilepsy (normal high resolution MRI), lesional but 
disconcordant scalp-EEG or other non-invasive findings, bitemporal or frontotemporal 
differential diagnostics and, rarely in TLE, delineation of eloquent areas (Wernicke) 
with a grid electrode (Diehl and Lüders 2000, Sinha et al. 2008).  
 
The main advantages of intracranial EEG electodes are improved spatial resolution 
and sensitivity to record, in particular, the higher EEG frequencies, which are 
attenuated in scalp EEG. With the invasive electrodes it is also possible to evaluate 
the deep structures of the brain, such as basal and mesial temporal structures, or 
interhemispheric areas. On the other hand, the disadvantage of subdural EEG 
electrodes is their limited coverage of the whole brain; and with intracerebral depth 
electrodes this recording coverage is even more restricted. If the actual seizure focus 
is outside of the area covered by electrodes, the electrodes are recording seizure 
spread instead of the initial onset of seizure. Siegel et al. reported a failure rate of 12 
% (13/110 patients) in localising the seizure origin with the invasive EEG methods 
used in their series. After re-evaluation of nine patients with intracranial EEG 
electrodes, satisfactory localisation of seizure onset could be achieved with seven 
patients, six of whom were seizure-free after surgical treatment (Siegel et al. 2000). 
The additional costs and possible complications related to these invasive procedures 
should always be taken into account, when the intracranial EEG evaluations with 
individual patients are considered.        
 
2.5.3.2.2  Intracranial electrodes 
 
Subdural strip electrodes are the devices most commonly used in invasive 
preoperative EEG evaluation of TLE patients. The strip electrodes consist of 4-10 
platinum or stainless steel contacts in a single row, which are placed directly on the 
cortex into the subdural space through burr holes. Placement of the electrodes is 
individually tailored according to the assumption of the seizure onset area suggested 
by previous non-invasive evaluation. The subdural strips are most commonly 
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introduced bilaterally, covering the temporobasal and temporal lateral lobes as well 
as a part of the frontal lobe, including the orbitofrontal cortex. Of course, the 
preferred setting varies among centres according to their established practise and 
indication for invasive electrodes.  
 
Intracerebral depth electrodes can be useful in cases of strictly mesial temporal 
epilepsy, e.g. bilateral hippocampal sclerosis, to define the side of seizure origin. 
Spencer et al. reported that using both depth and subdural electrodes 
simultaneously, the subdural electrodes were 20% less sensitive than depth 
electrodes for detection of seizures beginning in the hippocampus (Spencer et al. 
1990). Eisenschenk et al. showed that suboptimal placement of the subtemporal 
subdural strip electrode compared to the depth electrode recording may result in 
false localisation. When the subtemporal subdural electrode covers the 
parahippocampal area medially to the collateral sulcus, the seizures are definitely 
localised, congruent with the results from depth electrode recording (Eisenschenk et 
al. 2001). Accurate implantation of depth electrodes requires a sterotactic device 
using either the occipital route, implanting one electrode on each side along the axis 
of the hippocampus and finally entering the amygdala, or two electrodes through the 
lateral temporal cortex separately to the hippocampus and amygdala. The use of 
depth electrodes carries a higher risk of intracerebral haematomas, as it is being 
more invasive than subdurally placed electrodes. 
 
A grid electrode consists of multiple contacts embedded in a flexible sheet of silicone, 
which can be implanted in an open craniotomy to cover large areas of the cortex. In 
addition, to localise the zone of seizure onset, it can be used to delineate eloquent 
areas by cortical stimulation. Grid electrodes are primarily used to evaluate patients 
with extratemporal epilepsy. In cases of lateral neocortical temporal epilepsy or an 
associated temporal cortical lesion, the grid electrode may provide more definite 
information about the demarcation of the zone of seizure onset and allows 
stimulation of the Wernicke area on the dominant side during surgery.  
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2.5.3.2.3  Imaging of the electrodes 
 
After implantation of the electrodes, for detailed EEG analyses it is mandatory to 
visualise the position of the electrode contacts in relation to the cortical anatomy. 
This allows accurate delineation of the zone of seizure onset and is helpful in 
planning the surgical resection. Traditionally, the antero-posterior and lateral skull X-
ray films (two-dimensional, 2D) have been used for localising the subdural electrodes 
(Lesser et al. 1987), but development of the three-dimensional (3D) reconstructed 
MRI has allowed better interpretation of the position of the electrodes (Winkler et al. 
2000, Schulze-Bonhage et al. 2002). In this method, the preimplantation MRI is used 
to produce a 3D reconstruction of the anatomy of the cortical surface. The image is 
then registered with postoperative CT or MRI scan to localise the implanted subdural 
electrodes (Figure 4). Peroperative digital photography co-registered with 3D MRI 
data pinpoints the exact location of the grid and details the cortical anatomy 
underlying the subdural grid electrode (Wellmer et al. 2002, Mahvash et al. 2007). 
This can be applied only in open craniotomies, but it helps the surgeon to orient in 
resecting the area of epileptic focus and to avoid the eloquent cortical areas defined 
by video-EEG and extraoperative cortical stimulation.     
      
Figure 4. 3-D reconstructed MR images of the subdural grid and five strip electrodes. 
The patient had a low grade tumour in the right middle temporal gyrus and a history 
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of refractory daily seizures. The resection was tailored according to the findings in 
ictal video-EEG and the patient became seizure free. (A; inferior view, B; lateral view 
from right) 
 
2.5.3.2.4  Complications 
 
The proportion of patients requiring invasive EEG evaluation in epilepsy centres is 
diminishing due to development of non-invasive methods. There still remains a 
subgroup of patients for whom intracranial EEG evaluation is mandatory, and the 
risks and benefits must be weighed for each individual patient. Prospective studies 
by Swartz et al. and by Wiggins et al. showed that subdural electrodes are a safe and 
effective way of localising the epileptic focus (Swartz et al. 1996, Wiggins et al. 
1999). Since then, several retrospective series of complications related to invasive 
evaluation have been reported; and the rate of major adverse events causing 
permanent deficits appears to be low (Behrens et al. 1997, Rydenhag and Silander 
2001, Burneo et al. 2006, Tanriverdi et al. 2009). The most common complications 
reported in the literature are infections and haematomas. Invasive monitoring with 
grid electrodes is associated with most serious complications (Hamer et al. 2002, 
Burneo et al. 2006, Fountas and Smith 2007, Van Gompel et al. 2008, Wong et al. 
2009). In three of these articles, five deaths have been reported associated mainly 
with uncontrollable brain oedema. Most of the complications were, however, 
transient; and their occurrence was associated, e.g. with the larger and greater 
number of grids, longer duration of evaluation and older age of the patient. Subdural 
grid implantation seems to be better tolerated in children than in adults (Johnston et 
al. 2006, Musleh et al. 2006). It has been suggested that greater plasticity of 
paediatric brain tissue and veins, as well as greater tolerance for foreign bodies, 
could explain the lower rate of complications in the paediatric population.        
   
2.5.4  Operative treatment 
 
Epilepsy surgery requires multidisciplinary collaboration, and all patients who are 
being considered as candidates for surgery should undergo evaluation at the patient 
management conference. The core of the team should include, at minimum, an 
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epileptologist, a neurosurgeon, a clinical neurophysiologist, a neuroradiologist, a 
psychiatrist and a neuropsychologist. The main task of the team is to facilitate a 
consensus decision on whether the patient is a candidate for epilepsy surgery and 
whether there is enough evidence in the preoperative evaluation to proceed to 
surgical treatment. The need for intracranial EEG evaluation, surgical approaches 
and overall risks related to the selected treatment are discussed (Carreno and 
Lüders 2008).  
 
The primary data for the decision-making are obtained from structural MRI and 
recordings of ictal VTM-EEG. In patients with TLE if the MRI reveals a discrete 
structural abnormality in concordance with ictal EEG data, supportive data from the 
neuropsychological evaluation exist and molecular and functional imaging is 
congruent, the decision for curative surgery is justified. In the case of conflicting 
findings, palliative resective surgery may be considered, assuming that the expected 
outcome is thoroughly discussed at the patient management conference and the 
patient and his family are also counselled.    
 
2.5.4.1  Strategies for operative treatment 
 
Since the pioneer work by neurosurgeons Penfield, Bailey and Falconer on TLE 
surgery, many modifications of tailored and anatomical temporal lobe resections 
have been adopted. The variability seen even in classic anterior two-thirds 
lobectomies (ATL), including amygdalohippocampectomy, was reviewed for 47 
epilepsy centres participating in the second Palm Desert Conference. The median 
length of resection from the temporal tip was 5.5 cm in the nondominant lateral 
temporal cortex (range 2-6.5 cm), 4.5 cm on the dominant side (range 2-6 cm) and 3 
cm of the hippocampus (range 1-3.5 cm) (Spencer and Ojemann 1996).  
 
Ideally, removal of the epileptogenic zone leads to seizure control without any 
negative impact on cognitive functions, in particular, no adverse effects on 
postsurgical memory. In several studies classical anterior temporal lobe resection, 
including amygdalohippocampectomy vs. selective amygdalohippocampectomy 
(SAH), has been evaluated to determine its impact on the seizure outcome. Most of 
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the retrospective analyses have concluded that these different strategies for surgical 
approaches result in equally good seizure outcomes (Arruda et al. 1996, Clusmann 
et al. 2002, Paglioli et al. 2006). There are reports of worse outcome with paediatric 
patients undergoing SAH, which casts into doubt the existence of purely mesial 
juvenile TLE (Clusmann et al. 2004, Datta et al. 2009). In their retrospective study 
Bate et al. compared the seizure outcome in 82 patients with ATL and 32 patients 
with SAH and reported significantly better outcomes in the ATL group (Bate et al. 
2007).  
 
The impact of the extent of mesial or neocortical resection in TLE on the seizure 
outcome is controversial. Some studies show better seizure outcomes with extensive 
resection of the hippocampus or the entorhinal cortex (Wyler et al. 1995, Bonilha et 
al. 2007). Shamim et al. used postoperative MRI scans to calculate the resection 
volume after temporal lobectomy and concluded that the larger resection volume was 
associated with improved seizure control (Shamim et al. 2009). On the other hand, 
other reports indicate no benefit of more extensive resections with respect to seizure 
control (Wolf et al. 1993, Arruda et al. 1996, van Rijckevorsel et al. 2005). In their 
postoperative MRI controlled series, Joo et al. reported that greater resection of the 
hippocampus may predict better outcome, but this was not associated with the extent 
of resection of the lateral temporal gyri (Joo et al. 2005).  
 
In summary, there is marked variation among epilepsy centres in the extent and 
types of resection in temporal lobe surgery for epilepsy. Neither more selective types 
of resection nor larger extent of resection have ultimately proven to be better for 
achieving better seizure outcome.   
  
Many epilepsy centres have for decades used intraoperative electrocorticography 
(ECoG) to define the extent of both mesial and lateral temporal lobe resections. 
However, the use of intraoperative ECoG as a guide for resectioning in order to 
achieve better seizure outcome is controversial. The presence of spikes outside the 
boundaries of neocortical temporal resection areas guided by ECoG have not 
correlated with outcome (McBride et al. 1991, Cascino et al. 1995, Schwartz et al. 
1997). The recorded post-resection epileptic discharge did not correlate with the 
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outcome, nor did recorded post-resection discharge predict clinical seizures 
(Schwartz et al. 2000).  
 
Intraoperative hippocampal ECoG has also been used in guiding the tailored 
resection of the hippocampus, which may potentially allow the functionally important 
hippocampus to be left behind. In their series of 140 TLE patients, McKhann et al. 
found that hippocampal ECoG predicted how much hippocampus should be removed 
in order to maximise seizure-free outcome (McKhann et al. 2000). Intraoperative 
ECoG has also been used in predicting seizure outcome in selective 
amygdalohippocampectomies. Chen et al. reported that patients with spikes 
restricted to the mesiobasal temporal lobe more frequently remained seizure-free 
compared to patients with spikes laterally in the temporal lobe (Chen et al. 2006). 
ECoG has also been used to guide the extent of resection for removing lesions like 
the cavernous haemangiomas associated with temporal lobe epilepsy. The critical 
question is whether to remove only the lesion or to perform more aggressive 
resection in order to achieve better seizure control. In their series of 61 patients with 
temporal lobe cavernomas, Van Gompel et al. recently demonstrated that the use of 
intraoperative ECoG was associated with larger resection and improved the seizure 
outcome (Van Gompel et al. 2009).      
      
2.5.4.2  Surgical and neurological complications 
 
Resective surgery for TLE is associated with a broad variety of complications related 
to the complex anatomy and functions of the temporal lobe (Sasaki-Adams and 
Hadar 2008). Partial visual field defects (contralateral upper quadrantanopsia) are 
very common after temporal lobe resection, affecting about half of the patients (Manji 
and Plant 2000, Wiebe et al. 2001). However, most patients are unaware of this and 
these defects can be diagnosed only with detailed routine testing of the visual field 
(Egan et al. 2000).  
 
The surgical and neurological complications related to epilepsy surgery have been 
reported in a large multicentre study in Sweden (Rydenhag and Silander 2001). 
These researchers defined the complication as minor if it resolves within three 
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months and major if it affects activities of daily life and lasts longer than three 
months. Among the 449 therapeutic procedures reported, the most common minor 
surgical complication was infection, followed by hydrocephalus, cerebrospinal fluid 
leakage, haematoma and deep vein thrombosis/pulmonary embolism. Minor 
neurological complications included dysphasia and cranial nerve dysfunction, which 
affect the oculomotor or trochlear nerves. Major surgical complications affected one 
patient with infection and one patient with haematoma; the neurological deficits 
included hemiparesis (10 patients) and hemianopia (2 patients). The overall reported 
rate of minor complication was 8.9% and for major complications 3.1%. Another large 
single-centre study by Behrens et al. from Germany reported surgical complications 
in 7.8% of 429 therapeutic procedures, none of them resulting in permanent 
morbidity (Behrens et al. 1997). The total rate of neurological complications was 
5.4%, with 3.0% causing transient morbidity and 2.3% causing permanent morbidity. 
Neither of the above mentioned series reported mortality related to the surgical 
procedures. 
 
In a study involving only surgery for epilepsy of the temporal lobe (215 patients), 
Salanova et al  reported one patient with hemianopia, two patients with mild 
hemiparesis, seven patients with transient cranial nerve palsies and eight with 
transient language difficulties (Salanova et al. 2002). Sindou et al. reported the 
complications in a consecutive series of 100 patients with temporo-mesial epilepsy 
surgery; three patients had a haematoma, three patients had meningitis, two patients 
required shunt insertion and two patients had mild permanent hemiparesis (Sindou et 
al. 2006). No surgical mortality was reported in these series either.   
 
A recent study by Tanriverdi et al. reported the morbidity from a unique series of 
epilepsy surgery at a single institution in Montreal, Canada, involving 1905 patients 
who underwent 2449 therapeutic procedures performed by a single neurosurgeon 
(André Olivier) (Tanriverdi et al. 2009). No major surgical complications were 
reported, and infections (1.0%) and intracranial haematomas (0.7%) were the most 
common minor surgical complications. The rate of overall neurological morbidity was 
3.3% (minor 2.7%, major 0.5%) with hemiparesis being the most frequent 
neurological complication. No deaths were reported. However, in historical series 
before 1973 prior to the era of modern microneurosurgery, the mortality related to 
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epilepsy surgery has been reported to be 0.8 % -1.2% (Jensen 1975, Pilcher et al. 
1996).  
 
In summary, epilepsy surgery can be performed with an acceptably low rate of 
morbidity and is highly efficacious in treatment of refractory epilepsy.     
2.5.5  Seizure outcome of resective surgery  
 
The most widely used classification system for postoperative seizure outcome is 
adapted from Engel (Table 1) (Engel 1993). However, the category of patients free of 
disabling seizures (Class I) does not separate those patients with postoperative 
auras, and the outcome measure ‘≥50% seizure reduction’ is missing from the 
classification, which is typically used in antiepileptic drug trials (=Engel IVA). Taking 
into account these issues, the International League Against Epilepsy (ILAE) issued a 
commission report proposing a new outcome classification (Table 2), which also 
counts seizure days rather than total number of postoperative seizures (Wieser et al. 
2001).  
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Table 1. Engel’s classification of postoperative outcome (Engel 1993) 
 
Class I: Free of disabling seizures 
A Completely seizure free since surgery 
B Nondisabling simple partial seizures only since surgery 
C Some disabling seizures after surgery but free of disabling seizures for at 
least 2 years 
D Generalized convulsions with antiepileptic drug withdrawal only 
 
Class II: Rare disabling seizures  
A Initially free of disabling seizures but has rare seizures now 
B Rare disabling seizures since surgery 
C More than rare disabling seizures after surgery, but rare seizures for at least 
2 years 
D Nocturnal seizures only 
 
Class III: Worthwhile improvement 
A Worthwhile seizure reduction 
B Prolonged seizure-free intervals amounting to greater than half the follow-
up period, but not less than 2 years 
 
Class IV: No worthwhile improvement 
A Significant  seizure reduction  
B No appreciable change  
C Seizures worse  
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Table 2. Classification of outcome with respect to seizures according to the 
International League Against Epilepsy (ILAE 2001) 
 
Outcome classification Definition 
 
 
1 Completely seizure free, no auras 
 
2 Only auras, no other seizures 
 
3 One to three seizures days per year; ± auras 
 
4 Four seizure days per year to 50% reduction of baseline 
seizure days; ± auras 
 
5 Less than 50% reduction of baseline seizure days to 100 
% increase of baseline seizure days; ± auras 
 
6 More than 100% increase of baseline seizure days; ± 
auras 
  
 
In a systematic review of 126 articles from 1991 to 2000 concerning the outcome of 
TLE surgery, McIntosh et al. showed a wide range of freedom from seizures, from 
33% to 93% with a median of 70%. The major restrictions of this study were the short 
follow-up time, small sample sizes, dominance of cross-sectional methods and the 
heterogeneous definition of seizure outcome (McIntosh et al. 2001).  
 
The only randomised, controlled trial of surgery for TLE compared to AED treatment 
was conducted between 1996 and 2000 in Canada by Wiebe et al. At the one-year 
follow-up the proportion of seizure-free patients was 58% in the surgical group and 
8% in the medical trated group; and the quality of life, rates of employment and 
school attendance were better for patients who had undergone surgery (Wiebe et al. 
2001). 
 
Studies reporting the short-term seizure outcome for TLE show excellent results, but 
there is less information available on long-term seizure outcomes. The meta-analysis 
of 40 studies concerning TLE by Tellez-Zenteno et al. showed a 66% rate of seizure-
freedom with a follow-up time of over five years  (Tellez-Zenteno et al. 2005). 
Elsharkawy et al. recently reported that the rate of Engel I class outcome was 69 % 
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of 102 TLE patients monitored 16 years postoperatively (Elsharkawy et al. 2009). 
The long-term seizure outcome following selective amygdalo-hippocampectomy with 
369 patients reported by Wieser et al. showed an Engel class I outcome of 66.9 % for 
these patients (median follow-up time 7.4 years) (Wieser et al. 2003). The rate of 
freedom from seizures after TLE surgery remains satisfactory also in long-term 
follow-up, and the outcome at one year postoperatively seems to be a reliable 
indicator of the long-term Engel class I outcome (Cohen-Gadol et al. 2006). 
 
The seizure outcome in patients without any focal abnormalities in MRI has been 
reported to be significantly worse than in patients with hippocampal sclerosis or 
foreign tissue lesion on preoperative MRI. The study of Berkovic et al. showed that 
the postoperative rate of seizure freedom was only 21% in TLE patients with normal 
MRI (mean follow-up time 45 months); therefore the physicians may have been 
reluctant to consider surgery with these patients (Berkovic et al. 1995). Since then, 
several reports have shown better seizure outcomes in patients with normal MRI, but 
the patient series have been heterogeneous as have the preoperative evaluations. 
The rate of seizure-free patients varied from 41% to 60% in studies, that included 
only patients with temporal lobe epilepsy (Holmes et al. 2000, Sylaja et al. 2004, Bell 
et al. 2009). In studies that included both temporal and extratemporal origin of 
seizures, the rate of freedom from seizures was reported to be 45% to 63% (Engel 
class I) (Siegel et al. 2001, Alarcon et al. 2006, Bien et al. 2009) and 37% (ILAE 
class1) (Chapman et al. 2005). The overall conclusion drawn from results of recent 
studies supports the use of surgery in patients without any evident focal 
abnormalities in neuroimaging. 
 
2.6  Other treatment possibilities  
2.6.1  Gamma-knife surgery 
 
The idea of Gamma-knife surgery is to achieve seizure control similar to that with 
conventional resective epilepsy surgery in mesial temporal lobe sclerosis without the 
surgical risks related to open surgery and possibly minimising the neurocognitive 
defects after treatment. The disadvantage of radiosurgery is the delayed response up 
to three years for the seizure control. In addition, some patients may require 
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prolonged steroid treatment for the extensive oedema caused by radiosurgery.  The 
first gamma-knife treatment for mesial temporal lobe epilepsy was performed in 
France in 1993 (Regis et al. 1995), and since then prospective multicentre studies 
have shown seizure-remission rates comparable to those reported previously for 
open surgery (Regis et al. 2004, Barbaro et al. 2009). It has also been shown that the 
satisfactory seizure outcome is maintained in the long-term follow-up as well, with 
seizure-freedom rates of 47% to 60%. In both studies, however, the number of the 
patients was only 15 (Bartolomei et al. 2008, Rheims et al. 2008). On the other hand, 
other studies show no benefit from radiosurgery and a majority of those patients later 
had open surgery with excellent seizure outcome (Kawai et al. 2001, Srikijvilaikul et 
al. 2004, Vojtech et al. 2009). A prospective randomised study with a larger number 
of patients would reveal the possible advantages of radiosurgery over open surgery, 
but on the other hand, randomisation would be difficult due to the known delayed 
response of radiosurgery (Abou-Khalil 2004).  
 
2.6.2  Stimulation 
 
Neurostimulation is a novel treatment option, mainly for those epilepsy patients who 
cannot benefit from resective surgery. It has the advantage of reversibility and 
adjustability; but, on average, the effect of the treatment is considered to be 
palliative. Vagal nerve stimulation (VNS) is the only approved stimulation therapy in 
clinical use so far and shows a median reduction in seizures of 35-45% (Morris and 
Mueller 1999). The role of deep brain stimulation (DBS) is currently under intensive 
clinical research; and different targets such as the thalamus (Andrade et al. 2006), 
the subthalamic nucleus (Chabardes et al. 2002) and direct stimulation of the 
epileptic focus are being evaluated. In small clinical series, direct stimulation of the 
hippocampus in TLE has demonstrated potential efficacy in controlling seizures 
without memory deterioration (Boon et al. 2007, Velasco et al. 2007).  
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3  AIMS OF THE STUDY 
 
The general aim of this study was to evaluate the effect of presurgical, especially 
invasive, methods on seizure outcome of patients after TLE surgery. 
 
The more specific aims were: 
 
1. To evaluate the overall long-term seizure outcome in patients after TLE surgery. 
2. To evaluate the value of 3-D reconstructed MRI in localisation of subdural EEG 
electrodes. 
3. To evaluate a single centre strategy for preoperative evaluation and surgical 
treatment of TLE, in particular, the rate of complications after resective surgery 
and use of intracranial EEG electrodes.  
4. To evaluate the value of subdural EEG evaluation and surgical outcome in TLE 
patients without any focal abnormalities in MRI.  
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4  SUBJECTS AND METHODS 
 
4.1  Patients  
4.1.1  Patient population at Kuopio Epilepsy Center 1988- 2006  
 
The Kuopio Epilepsy Center in Kuopio University Hospital is a comprehensive centre 
for epilepsy surgery, serving an adult population of 4 million inhabitants in Finland 
and children from its own catchment area (~900,000 inhabitants). Between 1988 and 
2006, 229 adult patients underwent temporal lobe resection including 
amygdalohippocampectomy. During the same period, intracranial diagnostic 
evaluations were performed for 146 patients who had, according to the preoperative 
non-invasive evaluation, presumed temporal lobe epilepsy. One hundred and four of 
these 146 invasively evaluated patients for suspected temporal lobe epilepsy ended 
up having resective surgery.  
 
4.1.2  Patient population in Study I 
 
One hundred forty consecutive patients operated for TLE between 1988 and 1999 
were included. Patients with temporal lesionectomies only but without 
amygdalohippocampectomy and those for whom any extra-temporal cortical 
excisions had been carried out were excluded from the study. 
 
4.1.3  Patient population in Study II 
 
A 41-year-old female patient with a 35-year history of partial secondary generalised 
epilepsy without structural abnormalities in MRI was evaluated with intracranial 
subdural electrodes and operated on in the year 2000. 
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4.1.4  Patient population in Study III 
 
Between 1990 and 1999, 80 consecutive TLE patients with 84 intracranial EEG-
evaluations were included. In all of these patients TLE was suspected based on the 
results of non-invasive evaluation.  
 
Analysis of the complications was extended to cover all 146 invasively evaluated 
patients with suspected TLE between 1990 and 2006 and are thus reported in this 
thesis. During the same period the surgical and neurological complications of 
operated 229 adult patients with TLE were evaluated. Patients with any 
extratemporal resection were excluded as were patients with temporal 
lesionectomies without amygdalohippocampectomy. 
 
4.1.5  Patient population in Study IV 
 
Between January 1990 and December 2006, 146 patients with suspected TLE were 
evaluated with intracranial EEG-electrodes. Of these patients, 70 initially had MRIs 
that were interpreted as normal. After careful re-evaluation of the images, three 
patients turned out to have focal abnormalities in MRI and two others were excluded 
from the study due to the suboptimal quality of MRI (only low-field MRI available). In 
addition to temporal resection, one patient also had extratemporal surgery and was 
not included in this study. Thus after re-evaluation, 64 patients with normal high-
resolution MRI were included in Study IV.  After invasive video-EEG evaluation, 
resective surgery was performed on 38 patients. According to our agreed clinical 
protocol, patients with normal preoperative high Tesla MRI were not operated on 
without an invasive evaluation.  
 
4.2  Methods 
4.2.1  Preoperative evaluation  
 
In Study I the pre-surgical evaluation included MRI and ictal video-EEG recording 
(136 recordings with scalp-video-EEG with sphenoidal electrodes, of whom 50 were 
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evaluated with invasive intracranial EEG-electrodes), neuropsychological evaluation 
(n=135) and psychiatric evaluation (n=118). The surgical procedure was classified as 
“curative” if preoperative assessment indicated unilateral TLE. If the patient had 
evidence of bitemporal or multifocal epilepsy or if for some other reason, the epileptic 
focus could not be removed, the aim of surgery was classified as “palliative”. Some 
patients with dual pathology (i.e. hippocampal atrophy in combination with an 
extrahippocampal structural lesion in MR imaging), combined temporal and 
extratemporal abnormality (temporal lobe lesion other than hippocampal atrophy in 
association with an extratemporal lesion in MR imaging), bitemporal MR imaging 
abnormality, or temporal foreign-tissue lesion without ictal EEG were also classified 
as palliative.  
 
In Study IV all patients had been evaluated with ictal scalp- and intracranial video-
EEG, high Tesla MRI and psychiatric and neuropsychological testing. In the case of 
bitemporal seizure onsets in invasive EEG, patients with strong unilateral 
predominance (80% or more of the seizures originating from one temporal lobe) and 
very difficult symptoms were, however, considered to benefit from resective surgery.  
 
4.2.2  MRI 
 
In Studies I and IV, before February 1993 the preoperative MR imaging was 
performed with various kinds of scanners and imaging protocols available. In 
February 1993 high-resolution MR imaging with a standardised protocol for epilepsy 
became available at Kuopio University Hospital for presurgical evaluation. Since then 
all candidates for epilepsy surgery have been systematically scanned with a 1.5 - T 
Magnetom MRI device (Siemens: Erlangen, Germany). The brain was imaged with 
transaxial T2- and proton density-weighted and coronal T2-weighted sequences and 
a coronal 3D T1-weighted sequence (magnetization prepared, rapid acquisition 
gradient echo, MP-RAGE) 10/41/1 (TR, TE, excitations), inversion time 250 ms, flip 
angle 12° ; FOV 250 mm, matrix 256x192) tilted against the long axis of the 
hippocampus. In both studies the MR images were re-evaluated independently by 
two experienced neuroradiologists, who did not know the clinical details of the 
patients. 
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In Study II, anatomical T1-weighted MR images were acquired before implantation of 
the subdural strip electrodes. MR imaging was performed on a Siemens Vision 1.5 T 
scanner (Siemens: Erlangen, Germany) with a circular polarized head coil. 
Anatomical images were obtained using the 3D-MPRAGE sequence (repetition time 
= 9.7 ms; echo time = 4 ms; inverse time = 20 ms; flip angle = 12 degrees; 128 
sagittal slices; slice thickness 1.41 mm; field of view, FOV = 250 mm, matrix size 256 
x 256). For localisation of electrodes, computer tomography (CT) images were 
acquired after implantation of the subdural strip electrodes. CT imaging was 
performed on a Siemens Somatom Plus (Erlangen, Germany): 44 axial slices, slice 
thickness 3.0 mm, FOV = 205 mm, matrix size 512 x 512. Both MR and CT images 
were loaded to Curry 4.0 software (Neuro Scan, Inc., Sterling, Virginia). Four 
unequivocal landmarks (nasion, inion, left ear, right ear) were used for matching the 
internal coordinate systems of MRI and CT. The coordinates of subdural electrodes 
were digitized from CT images electrode by electrode and visualized on the cortical 
surface segmented from MRI. 
 
4.2.3  Invasive video-EEG (Study IV) 
 
The indications for invasive EEG evaluation with MR-negative patients were in the 
majority of cases bitemporal or unilateral frontotemporal differential diagnosis. 
Therefore, the electrodes were implanted according to a prejudged and individual 
plan to cover the frontal and temporal neocortical and temporal and orbitofrontal 
basal areas. The strip electrodes (ranging from four to eight contact electrodes) were 
introduced into the subdural space through two frontal and two temporal burr holes 
under general anaesthesia. For two patients, after failure in localisation of the ictal 
onset zone with subdural strip electrodes, intracerebral depth electrodes were later 
introduced. For one of these patients two electrodes were stereotactically (Leksell 
Stereotactic System, Elekta Corporate, Stockholm, Sweden) implanted on both 
sides, with target points on the hippocampus and the amygdala, using the lateral 
temporal approach. For the other patient, the occipital route was used, one electrode 
implanted to the hippocampus and the amygdala on each side. 
The ictal subdural EEG data were re-evaluated by two experienced specialists in 
clinical neurophysiology. When the first ictal electrographic onset appeared only on 
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the mesial electrode strip contacts, the seizure onsets were classified as 
”unitemporal mesial”. Accordingly, if the ictal onset occurred in temporal neocortical 
strips, or was seen simultaneously in mesial and neocortical temporal contacts, but 
not in other strips, seizures were judged as ”unitemporal neocortical +/- mesial”.  
”Bitemporal onset” refers to definite independent ictal onsets from both temporal 
lobes (either mesial or neocortical). For these seizures a unilateral predominance in 
seizure onsets was also evaluated by using the 80% cut-off point. Based on ictal 
onsets outside the temporal lobe strips, all other seizures were judged to be ”fronto-
temporal”, ”extratemporal” or ”multifocal” onset. Temporal EEG findings were further 
considered to be ipsilateral or contralateral to the operation side. 
 
4.2.4  Molecular imaging (Study IV) 
 
Interictal [18F] FDG-PET studies were performed at Turku PET Centre on 30 of 64 
patients (17/38 for operated patients) according to previously published methods 
(Lamusuo, et al. 2001). Interictal and/or ictal SPECT studies were performed at 
Kuopio University Hospital on 28 of 64 patients, for whom data from 22/64 patients 
were available for re-evaluation (13/38 for operated patients). Ictal and/or interictal 
SPECT- perfusion or benzodiazepine receptor studies were performed using a 
Siemens MultiSPECT3 gamma camera with fan-beam collimators (Kuikka et al. 
1993). [99mTC]ECD was used as a tracer for perfusion studies (Kuikka and Berkovic 
1994) and [123I]Iiomazenil or [123I]NNC-13-8241 for benzodiazepine receptor studies 
(Kuikka et al. 1996).The PET and SPECT studies were re-evaluated and graded as 
unilateral temporal or other (e.g. multifocal or contralateral). Furthermore, the findings 
in isotope imaging studies were graded as ipsilateral to the operated side or other 
(e.g. multifocal or contralateral).  
 
4.2.5  Resective surgery and complications 
 
In Studies I and IV, all operated patients underwent peroperative 
electrocorticography (EcoG) using two acutely implanted four-contact depth 
electrodes, inserted into the hippocampus and the amygdala separately, and 16 
neocortically placed surface EEG-electrodes. Intravenous methohexital (a single 40 
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m.g. bolus) and since 2005, propofol were used to enhance the possible occurrence 
of focal epileptic discharge in ECoG, while inhalation anaesthesia was withdrawn 
during ECoG registration.  According to the ECoG findings, the final extent of anterior 
temporal neocortical resection was tailored, but never exceeded 3.5 cm on the 
dominant and 4.0 cm on the nondominant side measured from the tip of the temporal 
pole. In Study IV, since 2001 the temporal neocortical resection was modified 
according to Spencer, leaving the upper temporal gyrus intact (Kim and Spencer 
2000). If the earlier video-EEG and acute ECoG showed no independent neocortical 
epileptiform activity, selective amygdalohippocampectomy was performed, including 
resection of the paparahippocampal gyrus. In that case the temporomesial structures 
were approached through the medial temporal gyrus.    
 
A complication was classified as major if it affected activities of daily living, lasted 
more than three months or included any significant neurological deficit. Minor 
complications resolved within three months. Information on causes of death was 
acquired from the Finnish National Registry of Mortality (Statistics Finland). 
 
4.2.6  Histopathology 
 
In studies I and IV the histopathological diagnosis was collected retrospectively from 
the medical records, and the interpretation of surgical specimens was re-evaluated 
by an experienced neuropathologist. The surgical specimens were taken from three 
defined neuroanatomical regions, i.e. hippocampal formation, amygdala and 
temporal pole.  Each tissue sample was grossly inspected, measured and cut in 
coronal slices. A selection of these slices were fixed in buffered formalin and 
embedded in paraffin for histological examination. Seven-micron thick sections were 
prepared and stained with a hematoxylin-eosin stain. Each section was evaluated 
under light microscopy for its representativeness. Lesions, such as gliosis in the 
molecular layer, satellitosis, gliosis in white matter, developmental alterations related 
to migration of neurons, hippocampal sclerosis or other pathological lesions, were 
searched for and recorded.   
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4.2.7  Seizure outcome and statistical analysis 
 
In Studies I and IV the seizure outcome was assessed according to a modified 
classification adapted from Engel using the complete classification with different 
subclasses (Engel 1993). Neighbourhood seizures (seizures occurring within one 
month postoperatively) were excluded from the analyses. Routine postoperative 
follow-up visits were scheduled for all patients at 3 months, 1 year and 3 years after 
the operation. Thereafter patients were either followed up at the center with clinic 
visits or contacted by telephone for additional historical details and up-to-date follow-
up. In problematic cases, medical records were obtained from other hospitals or 
community health centres. Whenever possible, the original prospectively collected 
seizure calendars were obtained.  
 
In Study I, seizure freedom was determined using the different Engel’s subclasses 
(Table 1). Seizure freedom refers to Engel’s subclass IA (patients who have been 
completely seizure free since surgery) at three months, one year and two years 
postoperatively. However, during long term follow-up (from 3 years onwards) seizure 
freedom refers to Engel’s subclasses IA, IC and ID. In Engel’s subclass IC patients 
may have some seizures after surgery, but they must have been free of disabling 
seizures for at least two years at the time of assessment. In Engel’s class ID, patients 
may have atypical generalized convulsions after antiepileptic drug withdrawal, but no 
other seizures. Patients with postoperative auras only (Engel’s subclass IB) were 
displayed separately at all time points, following the suggestions of the new ILAE 
classification (Wieser et al. 2001). In the subgroup analyses, patients who did not 
have seizures at three month follow-up (Engel IA) were considered initially seizure-
free. In the subgroup analyses of seizure-relapses, patients with Engel’s subclasses 
IC and ID were not re-considered to be seizure-free after the first postoperative 
seizure. In Study IV, Engel’s main class I (including Engel’s subclasses IA- D) was 
used to describe postoperative freedom from disabling seizures. 
 
In Studies I and IV, Engel’s class II refers to all patients who have rare seizures 
(fewer than 3 per year) postoperatively (Engel’s subclasses IIA- C). In subclass IIA 
patients were originally seizure-free, but have rare seizures at the time of the 
assessment. In subclass IIB patients have rare seizures after surgery. In subclass IIC 
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patients may originally have more than rare postoperative seizures, but they must 
have had only rare seizures for at least 2 years at the time of assessment. Engel’s 
class III refers to a reduction in seizure frequency of at least 80% postoperatively 
(worthwhile seizure reduction). Engel’s class IV refers to a less than 80% seizure 
reduction postoperatively (no worthwhile improvement in seizure frequency, Engel’s 
subclasses IVA- C). This includes patients with a seizure reduction of at least 50% 
(subclass IVA), patients with no change from preoperative seizure frequency and 
severity of seizures (subclass IVB), or patients with more frequent (an increase in 
seizure frequency of at least 50% postoperatively) or more severe seizures than 
preoperatively (subclass IVC). According to the Engel’s classification during long-
term follow-up, the seizure outcome data from preceding last two years is used for 
the assessment. 
 
In Study IV, Engel’s classes I and II were considered to be “favourable outcome” and 
Engel’s classes III and IV “poor outcome”.  
 
In Study I, the statistical software SPSS WIN 9.0 software (SPSS Inc., Chicago, IL, 
USA) and in Study IV the version of SPSS for Windows 16.0 were used for statistical 
analysis. In Study I, the postoperative outcome was analysed using the Chi-square 
test     for     comparisons     between     patient     groups.     The     existence     of 
significant differences was defined as a probability value (p) < 0.05, and in Study IV 
the two-tailed Fisher’s exact test was used. 
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5  RESULTS 
 
5.1  Patient demographics 
5.1.1  Study I 
 
The median age of the patients at the time of the operation was 32 years (range 14 
to 54 years). The median age at onset of epilepsy was 12 years (range 0.1 to 43 
years), and median duration of epilepsy at the time of operation was 19 years (range 
2 to 47 years). During the year preceding the operation, the preoperative frequency 
of seizures varied from 10 to 1655 seizures per year (median 78).  
 
On the basis of the preoperative assessment, 103 patients (74% of all patients) had 
concurrent evidence of unilateral TLE. For them, the aim of surgery was judged 
preoperatively as “curative”. For an additional 37 patients the surgery was palliative. 
These 37 patients had bitemporal onset of seizure (n=18), unitemporal but 
extratemporally extending onset of seizure (n=6), multifocal epilepsy (n=2), dual 
pathology (n=2), combined temporal and extratemporal abnormality (n=2), bitemporal 
MR imaging abnormality (n=2), or posterior neocortical onset of seizure in the 
dominant temporal lobe together with ipsilateral speech dominance (n=2). 
Furthermore, three patients with temporal foreign-tissue lesion without ictal EEG 
were classified as palliative. 
 
5.1.2  Study IV 
 
The mean age at the time of intracranial EEG electrode implantation was 31 years 
(range 15-51 years). Mean age at the onset of seizures was 16 years (range 1-40 
years) and the mean duration of epilepsy was 15 years (range 2-43 years).  
 
Sixty-six intracranial recordings were performed for 64 patients. Two patients of the 
64 had a combination of subdural and intracerebral depth electrodes, and in two 
patients a second invasive EEG-recording was performed only with depth electrodes. 
Finally, for 26 patients it was not possible to identify the area of seizure onset, thus 
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preventing us from proceeding to the resective surgery. For 16 patients the onsets of 
seizures were probable extratemporal or multifocal, 2 patients had a seizure onset 
near or at the eloquent area and 4 had independent bitemporal seizures. Finally, in 
20 patients no further surgical evaluation was recommended, and the antiepileptic 
medication was optimised. In two patients a vagus nerve stimulator was implanted. 
Two patients were seizure-free after the EEG evaluation, and two patients 
experienced no seizures even during a prolonged (21 days) period of invasive EEG-
registration.  
 
During the same period we operated 126 MRI-positive TLE patients without invasive 
recordings and 63 MRI-positive patients with invasive EEG recordings. In addition, 
two patients with low-field MRI and one patient with larger than only temporal 
resection were operated after intracranial EEG-evaluation. The MRI-negative 
operated group (N= 38) constitutes 17% of all adult TLE-patients (N= 229) operated 
in our hospital during the same period.  
 
5.2  MRI 
5.2.1  Unilateral TLE (Study I) 
 
Qualitative MR imaging demonstrated unilateral structural abnormality in the 
temporal lobe in 53% (n=55) of the patients with unilateral TLE. This included 
hippocampal atrophy with (n=9), or without (n=24) temporal cortical atrophy, and 
other unilateral structural lesions of the temporal lobe (n=22). MR imaging showed 
other abnormalities in 13% (n=13) of patients and it was judged as normal in 34% of 
the patients with unilateral TLE (n=35). The MR-imaging data were also evaluated in 
subgroups of patients imaged before or after introduction of a standardised MR-
imaging protocol for epilepsy (operated on between December 1988 and January 
1993 or February 1993 and December 1999, respectively). In the earlier group (1988 
- 1993) MRI demonstrated structural abnormalities in 35% (n=17) of patients and in 
the later group (1993 - 1999) in 70% (n=38, p<0.001). The difference in the rate of 
abnormal findings probably reflects the improved MRI protocol.  
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5.2.2  Patients with palliative operations (Study I) 
 
The largest subgroup among the palliatively operated TLE patients were those with 
normal qualitative MR imaging (n=13). When the MR-imaging data in subgroups of 
patients imaged before or after the introduction of a standardised MR-imaging 
protocol for epilepsy were evaluated, the changes were similar to those observed in 
unilateral TLE (p<0.05). Between December 1988 and January 1993, a unilateral 
structural abnormality of the temporal lobe was found in 8% (n=1), and the MR-
imaging was interpreted as normal in 62% (n=8) of palliative patients. Thirty-one % 
(n=4) had dual pathology or concomitant temporal and extratemporal abnormality.  In 
the later group (between February 1993 and December 1999) MRI demonstrated 
structural abnormality in 38% (n=9) and normal MR imaging in 21% (n=5). An 
additional 25% (n=6) of patients had dual pathology, concomitant temporal and 
extratemporal abnormality or extratemporal pathology, leaving 17% (n=4) for other 
aetiologies. 
 
5.2.3  3-D reconstructed MR imaging (Study II) 
 
In Study II the locations of the EEG electrodes were visualised on the segmented 
cortex of the 3-D reconstructed MR-images. Unexpectedly, the tips of both 
orbitofrontal and temporal strip electrodes were lying close to each other in the area 
of the right mesial temporal lobe, thus verifying that both of the electrodes involved in 
seizure onset were localised in the right temporal lobe.  
 
5.3  Intracranial EEG (Study IV) 
 
Among the 38 operated patients, according to the invasive ictal video-EEG 
monitoring the onset of the seizure could be defined in the unilateral temporal mesial 
area in 25 patients (66%). The ictal onset was unilateral neocortical +/- mesial in 29 
of the patients (76%), bitemporal in 6 patients (16%) and frontotemporal or multifocal 
in 3 patients (8%). In bitemporal cases, unilateral predominance of 80% or more was 
found in all 6 patients.  
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5.4  Molecular imaging (Study IV) 
 
PET showed an area of ipsilateral temporal hypometabolism in 10 patients, which 
was in concordance with ictal onset in invasive EEG recording; and extratemporal 
changes were seen in 7 patients. Interictal or ictal SPECT showed an ipsilateral 
temporal finding in 4 patients and other extratemporal locations in 9 patients.  
 
5.5  Surgical procedures 
 
In Study I, the operative procedures included anterior temporal resection and 
amygdalohippocampectomy, alone (n=113) or combined with lesionectomy (n=9), 
and selective amygdalohippocampectomy (n=18).  
 
In Study IV, based on the peroperative electrocorticography findings, anterior 
temporal resection and amygdalohippocampectomy was performed in 30 patients 
and selective amygdalohippocampectomy in eight patients (21%). Twenty-three 
patients (61%) were operated on the left side and 15 (39%) patients on the right side.  
 
5.6  Complications related to the surgical procedures and the rate of mortality 
5.6.1  Resective surgery 
 
Major complications related to resective surgery included prolonged dysphasia in one 
patient, homonymous hemianopia in three patients, and subarachnoidal 
haemorrhage caused by an intraoperative depth electrode in one patient. This last 
patient experienced prolonged dysphasia, which resolved completely within one year.  
 
The most frequent minor complications included chronic subdural haematoma in 5 
patients, who were treated with trephination and drainage. Two patients had subdural 
effusion, which resolved without further operative treatment. Six patients had 
postoperative probable aseptic meningitis without microbiological verification, one 
patient needed shunt insertion due to the hydrocephalus, and in one patient a bone 
lambeau infection was noted. One patient experienced deep vein thrombosis, and 
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one had to be reoperated within a week due to cerebrospinal leakage through 
mastoid cells. Six patients experienced dysphasia, which resolved completely within 
three months. The total rate of major complication was 2% (5/229) and for minor 
complications 10% (23/229) (Table 3). 
 
Table 3. Surgical and neurological complications related to temporal resection in 229 
operated patients. 
 
 
Complication      Minor  Major 
 
 
Surgical 
  
 Haemorrhage, peroperative        1 
  
 Chronic subdural haematoma/hygroma    7 a     
  
Aseptic meningitis        6 b 
 
Hydrocephalus        1  
 
Lambeau infection        1   
  
 Deep vein thrombosis       1 c 
    
 Cerebrospinal fluid leak from the nose,     1   
 reoperation      
 
 
Neurological 
 
 Homonyme hemianopia            3 
 
 Dysphasia         6     1 
  
 
    
Total number of complications    23    5 
Total number of patients with complications 21     5 
 
a Five chronic subdural haematomas evacuated and two subdural effusions 
  treated conservatively.    
b One patients with transient dysphasia had also aseptic meningitis. 
c One patient with transient dysphasia had also deep venous trombosis. 
  47
5.6.2  Intracranial EEG-evaluation 
 
Among the 146 patients with intracranial EEG-monitoring, 36 (25%) showed transient 
complications related to invasive evaluation: 24 patients experienced cerebrospinal 
fluid leakage from the wound, four patients had suspected meningitis with fever but 
without bacteriological verification. Two patients had transient third cranial nerve 
palsy, which was probably due to direct compression of the oculomotor nerve by a 
subtemporal strip electrode, which resolved within days after the electrode was 
pulled out about one centimetre. Two patients experienced transient diplopia; and 
one had an asymptomatic subdural haematoma, which was revealed by the 
postoperative CT imaging used for localising the electrodes. One patient had an 
asymptomatic subdural haematoma near the subtemporal strip electrode, which 
prevented proper recording from those contacts; and a new intracerebral electrode 
was therefore inserted through the same burr hole to the ipsilateral hippocampus. 
The invasive EEG evaluation could be completed, but later the patient developed 
temporal lobe encephalitis without microbiological verification. This patient was 
treated with antibiotics and corticosteroids and recovered without neurological or 
neuropsychological deficits. One patient experienced a middle ear infection, treated 
with antibiotics, and one had transient hyponatremia (Table 4). Despite the 
complications described above, for all patients the invasive EEG evaluation could be 
completed as planned; and no complications causing permanent neurological deficits 
were noted.  
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Table 4. Surgical and neurological complications related to intracranial EEG 
evaluation during 1990-2006 in 146 patients with suspected TLE. 
 
 
 
 Cerebrospinal fluid leak from the wound            24 (16%) 
 
 Suspected meningitis, no microbiological  4  (3%) 
 verification  
 
 Transient paresis of third cranial nerve   2  (1%) 
 
 Diplopia, transient      2  (1%) 
     
 Subdural hematoma, asymptomatic    1  
  
 Subdural hematoma and postoperative   1  
 encephalitis 
 
 Middle ear infection      1  
 
 Hyponatremia      1  
 
  
        36/146 (25%) 
 
 
5.6.3  Mortality 
 
In Study I, six patients died during the follow-up. Two of these patients had been 
completely free of seizures postoperatively (14 and 27 months), and four had an 
unfavourable surgical outcome. The causes of death related to epilepsy (4 out of 6) 
were sudden unexpected death in epilepsy, suicide (depression related to poor 
seizure control), and prolonged epileptic seizure (n=2). No mortality was directly 
attributable to the surgical procedures. 
 
5.7  Histopathology 
 
In Study I, the pathologic examination of resected tissue displayed three different 
entities: patients with hippocampal sclerosis or gliosis (n=60), patients with tumour or 
cystic lesion (n=18), and patients with cortical microdysgenesis (n=17). Hippocampal 
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sclerosis was confirmed in 41 of 46 symptomatic patients with hippocampal atrophy 
in the preoperative MR imaging. Focal cortical dysplasia was observed in one 
patient, and benign or low-grade tumour (dysplastic neuroepithelial tumour, 
ganglioglioma, hamartoma, or oligodendroglioma) in six patients, who were 
evaluated preoperatively as suffering from probable symptomatic focal epilepsy.  
 
In Study IV, 26 subjects (68%) did not display any definite pathological findings in 
any of their surgical specimens. In two subjects, only a microscopically identifiable 
tumour was observed, one defined as an oligodendroglioma and one as a 
dysembryoplastic neuroepithelial tumour. In two patients migrational alteration, i.e. 
cortical microdysgeneses, was observed. Only two patients displayed definite 
hippocampal sclerosis, i.e. neuronal loss and gliosis, within the CA1 region; and in 
six patients prominent gliosis without neuronal loss was seen. 
 
5.8  Seizure outcome (Engel´s Classification) 
5.8.1  One year outcome (Study I) 
 
In patients with unilateral temporal lobe epilepsy 45% (n= 46) were completely 
seizure free and 12% (n=12) had only postoperative auras one year after the 
operation. Rare seizures (Engel II) were identified in 12% of the patients (n=12). 
Engel I-II outcome was thus observed in 68% of these patients. In addition, 13% of 
the patients (n=13) had a worthwhile reduction in seizures (Engel III), while 19% (n= 
19) did not benefit from surgery (Engel IV). One patient died due to a prolonged 
epileptic seizure three months after the operation. 
 
In patients with palliative operations 27% (n= 10) were free of seizures, 3% (n=1) had 
only postoperative auras, and 8% (n=3) had rare seizures. In addition, 24% (n=9) 
achieved a worthwhile reduction in seizures. A minimum of 80% reduction in seizures 
was therefore achieved by 62 % of these patients. 
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5.8.2  Long-term outcome (Study I)  
 
In patients with unilateral TLE, the results of the long-term follow-up did not differ 
from those of the one-year follow-up (p>0.05 between groups). On the latest 
available follow-up date (mean follow-up 5.4 ± 2.6 y, range 3 months –10.5 y) 46% 
(n= 47) of the patients were seizure free; 10% (n=10) had only postoperative auras, 
and 15% (n=15) had rare seizures. In addition, 13% of the patients (n=14) achieved a 
worthwhile reduction in seizures and 16% (n= 17) did not benefit from surgery (Engel 
IV). 
 
In patients with palliative surgery, on the latest available follow-up date 35% (n= 13) 
of patients became seizure free, 5% (n=2) had rare seizures and 22% (n=8) achieved 
a worthwhile reduction in seizures. The mean follow-up was 4.4 ± 2.2 years (range 
1.0 -9.0 years). Also in palliative patients the results of long-term follow-up did not 
differ from those of one-year follow-up (p>0.05 between groups,). 
 
5.8.3  Analysis of outcome before and after standardised MR imaging protocol 
for epilepsy (Study I) 
 
The results were independently evaluated in patients operated on with or without a 
standardised preoperative MR-imaging protocol for epilepsy. There was a significant 
difference in the postoperative outcome between these two groups (p≤0.001 for one-
year outcome). Forty-nine patients with unilateral TLE were operated on before the 
introduction of a standardised MR imaging protocol for epilepsy (between December 
1988 and January 1993). One year after the operation 61% (n= 30) of the patients 
achieved Engel I-II outcome, with only 27% (n=13) being seizure free. In the long-
term follow-up (latest available follow-up data, median 7.7 years, range 1.0 - 10.5 
years) 39% (n=19) of the patients became seizure free, 12% (n=6) had only 
postoperative auras, and 12% (n=6) had rare seizures. In addition, 19% (n=9) of the 
patients achieved a worthwhile reduction in seizures, while 18% (n=9) had no 
worthwhile reduction in seizures. A total of 54 patients with unilateral TLE were 
operated on after the introduction of a standardised MR-imaging protocol for epilepsy 
(from February 1993 to December 1999). One year after the operation 61% (n=33) of 
them were free of seizures, 11% (n=6) had only postoperative auras, and 2% (n=1) 
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had rare seizures. Moreover, 11% (n=6) achieved a worthwhile reduction in seizures. 
On the latest available follow-up date (median follow-up 3.8 years, range 3 months -
6.5 years) 52% (n=28) of the patients were seizure free, 7% (n=4) had only 
postoperative auras, and 17 % (n=9) had rare seizures. Nine percent (n=5) of the 
patients achieved a worthwhile reduction in seizures. Taken together, after the 
introduction of a standardised MR-imaging protocol for epilepsy, 74% of patients with 
unilateral TLE achieved Engel I-II outcome in the one-year follow-up and 76 % of 
patients in the long-term follow-up (Figure 5).  
 
When the outcome was analysed in subgroups of palliative TLE patients operated on 
before or after the introduction of a standardised preoperative MR imaging protocol 
for epilepsy, trends of improved outcome similar to those in patients with unilateral 
TLE were observed (p>0.05). Twenty-four patients were operated on after the 
introduction of a standardised MR imaging protocol for epilepsy (between February 
1993 and December 1999). On the latest available follow-up date (median follow-up 
3.1 years, range 1.1 -6.8) 42% (n=10) of these patients were free of seizures, 4 % 
(n=1) had rare seizures, and 25% (n=6) achieved a worthwhile reduction in seizures. 
An at least 80% reduction in seizures (Engel I-III outcome) was therefore achieved by 
71% (n= 17) of the palliative patients operated on after the introduction of a 
standardised MR-imaging protocol for epilepsy in the long-term follow-up (Figure 5). 
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Figure 5. Long-term outcome with respect to 
seizures according to the Engel’s 
classification. All unilateral TLE and 
palliatively operated TLE patients between 
1988-1999 (A and B). Patients with unilateral 
TLE before and after a standardised MR 
imaging protocol (C and D). Palliatively 
operated TLE patients before and after a 
standardised MR imaging protocol (E and F). 
MRI negative TLE patients (G). 
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5.8.4  Late seizure relapse (Study I) 
 
Eighty-six percent (71 of 83) of all seizure relapses occurred within one year after the 
operation. Late relapses were often preceded by a specific explanatory factor such 
as withdrawal of antiepileptic medication (n=3) or hyponatremia (n=1), and in none of 
the patients did this lead to subsequent persistent intractability during the follow-up. 
 
Initially, 63% (88 of 140) of all patients were seizure free or had only postoperative 
auras at the first postoperative control visit (three months postoperatively). Of these, 
53% (47 of 88) remained completely free of seizures also in the long-term follow-up 
(mean 5.2 ± 2.6 years, range 1.0-10.5 years), whereas 5% (4 of 88) experienced 
some seizures but again became seizure free (for at least two years). In addition, 
11% (10 of 88) had only postoperative auras and 15% (13 of 88) had rare seizures.  
 
5.8.5  Outcome with respect to seizures and predictive factors (Study IV) 
 
In Study IV after one-year follow-up, 45% (17 of 38) of the patients had favourable 
outcome; 40% (n=15) had Engel class I and 5% (n=2) had Engel class II. Of the 
patients, 55% (21 of 38) had poor outcome after 12 months follow-up; 21% (n=8) had 
Engel class III and 34% (n=13) had Engel class IV.  
 
The latest follow-up lasted mean 5.8 years (median 4.8 years, range 1.1-14.3 years). 
In addition, one patient died due to SUDEP three months after the operation with an 
outcome of Engel class IV at that time. His outcome has been taken into account in 
the analysis by carrying the last observation forward.  At the latest follow-up 45% (17 
of 38) of the patients had favourable outcome (40% (n=15) had Engel class I and 5% 
(n=2) had Engel class II). Twenty-one patients out of 38 had poor outcome (10 Engel 
class III and 11 Engel class IV).  The outcome did not change between the 12-month 
follow-up and the latest follow-up (Figure 5).  
 
Eight predictive factors were selected prospectively and evaluated as potential 
predictors of postoperative seizure outcome. Patients with noncongruent PET results 
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had the worst outcome (p=0.044); none of the other factors evaluated were 
statistically significant (Table 5). 
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Table 5. Analysis of predictive factors for seizure outcome at the latest postoperative 
follow-up in MR-negative temporal lobe epilepsy patients. 
 
 
       n  Engel I-II Engel III-IV  F, p      
 
All      38 17 (45%) 21 (55%) 
 
Gender 
Female    23 13 (57%) 10 (43%)      p=0.100 
Male    15  4  (27%) 11 (73%)  
  
Duration of epilepsy  
≤ 10 years    15 8  (53%) 7  (47%) - 
11-20 years    9 0  (0%) 9  (100%) 
≥ 21 years    14 9  (64%) 5  (36%) 
 
Invasive ictal EEG onset  
Ipsilateral to operated side 29 13 (45%) 16 (55%) p=1.000 
Other     9  4  (44%)  5  (56%) 
 
SPECT  
Ipsilateral to operated side  4 3  (75%) 1  (25%) p=0.266 
Other     9 3  (33%) 6  (67%) 
 
PET  
Ipsilateral to operated side 10 5  (50%) 5  (50%) p=0.044 
Other     7 0   (0%) 7  (100%) 
 
Surgery 
ATL + AH    30 13 (43%) 17 (57%) p=1.000 
Selective AH    8  4  (50%)   4 (50%) 
 
Side of surgery 
Right    15  6  (40%)  9   (60%) p=0.744 
Left     23 11 (48%)  12 (52%) 
 
Pathology 
Focal pathology   12 6   (50%)  6  (50%) p=0.734 
No focal pathology  26 11 (42%) 15 (58%) 
 
 
                                        
 
F,p        = Fisher’s exact test, p-value 
ATL     = anterior temporal lobe resection 
AH       = amygdalohippocampectomy 
SPECT = single photon emission computed tomography 
PET      = positron emission tomography 
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6  DISCUSSION  
 
In Finland, a comprehensive programme of epilepsy surgery was first established at 
Kuopio University Hospital, and the evaluation and surgical treatment of refractory 
epilepsy patients started in 1988. Before that the multidisciplinary epilepsy surgery 
team was trained at one of the most advanced epilepsy surgery centres, Montreal 
Neurological Institute in Montreal, Canada. In Finland, the first invasive intracranial 
EEG evaluations were performed in 1990. A majority of the operated patients have 
been adults with refractory TLE from a defined geographical area in Finland having a 
population of 4 million inhabitants. The present series of studies were based on the 
preoperative evaluation, surgical treatment and systematic follow-up of adult TLE 
patients treated at Kuopio University Hospital between 1988 and 2006.    
 
6.1  Methodological considerations 
 
Study I is a comprehensive analysis of the longitudinal follow-up of refractory TLE 
patients from consecutive series between 1988 and 1999. The strength of the study 
is that it has a long-term follow up from a relatively well-defined population. Nearly all 
adult TLE operations in a population of 4 million inhabitants in Finland were 
performed at Kuopio Epilepsy Center. The new preoperative MRI protocol seems to 
detect structural abnormalities more accurately than was the case before January 
1993. Had the new protocol been in use during the the whole study period it might 
have had a beneficial impact on the results.  
 
In Study IV, all patients without any focal abnormalities in high resolution MRI were 
systematically evaluated with intracranial EEG electrodes in a consecutive series 
between 1990 and 2006. During these years the MRI methods had developed 
considerably, which leads to the fact that some previously MRI-negative patients 
might now be MRI positive if scanned with current MRI methods. Moreover, 
molecular imaging (SPECT, PET) studies were not applied systematically, and 
therefore no firm conclusions can be made concerning their role in preoperative 
work-up. On the other hand, the operative techniques related to resective surgery 
and intracranial EEG evaluation remained uniform throughout the study period. 
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In both studies (I, IV) the mean follow-up was about five years, which is meaningful 
for assessment of the long-term outcome of epilepsy surgery.  
   
6.2  Seizure outcome 
 
The data obtained in Study I demonstrated that 57% of the unilateral TLE patients 
achieved Engel I outcome at one-year follow-up compared to 30% in the subgroup of 
palliative patients. In long-term follow-up the rate of Engel class I outcome was 
observed in 56% of patients with unilateral TLE and in 35% of palliatively operated 
patients. Our findings are in line with reported results of long-term seizure outcome 
after temporal lobectomy in a series of 325 patients (McIntosh et al. 2004). 
 
Not surprisingly, the seizure outcome in a subgroup of palliative patients was worse 
than that for patients with unilateral temporal seizure focus. Surgical treatment of 
bitemporal epilepsy after invasive EEG evaluation is, however, also beneficial, even if 
the total freedom from seizures is not achieved (Boling et al. 2009). In Study I, 54% 
of our palliatively operated patients had bitemporal seizure onset or bitemporal MRI 
pathology. 
 
It was shown in the present study that 86% (71/83) of seizure relapses occurred 
within the first postoperative year, thus indicating that the outcome at one-year 
follow-up was predictive of long-term outcome. Cohen-Gadol et al. reported similar 
results at the 1st year follow-up, this being a reliable indicator also of the long-term 
Engel class I outcome (Cohen-Gadol et al. 2006). The large meta-analysis of long-
term seizure outcome by Tellez-Zenteno et al. showed the long-term outcome in TLE 
to be similar to the outcome in short-term controlled studies (Tellez-Zenteno et al. 
2005). According to the two long-term follow-up studies, the likelihood of remaining 
seizure free after the two first years of freedom from seizures was 90% (Elsharkawy 
et al. 2009) and 86% (Foldvary et al. 2000).  
 
Our data indicate that 53% of the initially seizure-free patients remained completely 
seizure-free (Engel class 1A) on long-term follow-up (mean 5.2 years). Yoon et al. 
reported that with patients who were seizure-free at one-year follow-up after 
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resective surgery, the likelihood of remaining seizure free declined to 56% over ten 
years; but half of the patients who relapsed had at most one seizure per year. In their 
series the longer duration of epilepsy before surgery and normal pathological findings 
were predictive factors for poorer outcome (Yoon et al. 2003).      
 
Our results also demonstrate that epilepsy surgery can be beneficial for patients with 
TLE and nonlesional MRI. At the latest follow-up (mean 5.8 years) 40 % of our 
patients achieved Engel class I outcome, and the outcome did not change between 
the one-year and the latest follow-up. 
 
6.3  The role of MRI 
 
Standard MRI protocols fail to detect up to 50% of the lesions in epilepsy patients 
with refractory epilepsy (Von Oertzen et al. 2002). Therefore it has been suggested 
that a specific, pre-planned epilepsy protocol should be used. This was also shown 
here in the present Study I, when after introducing a standardised epilepsy imaging 
protocol in February 1993, the rate of unilateral structural abnormalities discovered in 
preoperative MRI increased from 35% to 70% in patients with unilateral TLE. Of 
course, improvement in MRI techniques from the early 1990’s onward is likely to 
have facilitated detection of abnormalities. The seizure outcome was analysed before 
and after a standardised imaging protocol for epilepsy was introduced, and improved 
outcome trends were seen in unilateral TLE as well as in a subgroup of palliative 
patients operated after February 1993.     
 
The diagnosis of unilateral HS on MRI has a positive predictive value for seizure 
outcome after surgery (Berkovic et al. 1995, Gilliam et al. 2000). Patients are often 
less likely to be operated on when no hippocampal anomalies are detected on MRI, 
which further underlines the impact of specific MRI protocol on patient management 
and emphasizes the importance of adequate imaging.  
 
Earlier it was thought that mild MCDs and type I FCDs could not be detected in MRI, 
but recently MRI abnormalities have also been described for these pathologies 
(Krsek et al. 2008, Widjaja et al. 2008). The FCDs most frequently identified on MRI 
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are type II or Taylor-type FCDs; however, MRI still can be normal in FCD found in 
subsequent pathological samples (Bronen et al. 1997, Chan et al. 1998, Lee et al. 
1998).  
 
In our study, 44% of patients with suspected TLE and evaluated with intracranial 
EEG electrodes had normal MRI scans.  Possible reasons include (a) a subtle form 
of MTS that is not apparent on MRI; (b) other pathology of the medial temporal lobe, 
such as microdysgenesis, not visible on MRI; or (c) temporal neocortical pathology, 
such as mild forms of cortical dysplasia, not detected by MRI. In Study IV, 68% of the 
operated patients with MRI-negative TLE did not display pathological alteration in any 
of their surgical specimens. Subtle pathology may not have been detected, especially 
when present in neocortical areas.  
 
The development of 3T MR-imaging has enabled neuroradiologists to detect relevant 
abnormalities related to focal epilepsy with previously unremarkable 1.5 T scans 
(Knake et al. 2005, Strandberg et al. 2008). Focal temporal MRI findings correlate 
positively with the seizure outcome of TLE surgery. Therefore, patients who could be 
candidates for surgical treatment based on their clinical results, and who have had 
previously unremarkable MRI scans, should be rescanned when more advanced 
equipment and methods become available. However, high-sensitivity MRI will detect 
even subtle lesions, which may not be in concordance with other findings in 
preoperative evaluation, thus also being, at least theoretically, misleading. This 
stresses the importance of having a multidisciplinary team for epilepsy surgery. The 
MRI findings should thus be interpreted against all other data available at the 
presurgical evaluation work-up. 
 
Since 1999, 3-D reconstructed MR-imaging was implemented for visualisation of the 
intracranial EEG electrodes after their implantation; before that, only a skull X-ray 
was used for localising the electrodes. We demonstrated the crucial role of the 3-D 
reconstructed MRI with one MRI-negative TLE patient who showed ictal onset from 
both frontal and temporal subdural strip electrodes. According to the 3-D MRI 
images, the frontal electrode was actually recording the temporopolar ictal activity; 
and a selective amygdalohippocampectomy was performed based on the results of 
the intraoperative EcoG, which showed no temporal neocortical epileptiform 
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discharge. Postoperatively, the patient was seizure free (Engel class IA). Without the 
exact information provided by the 3D imaging the patient would have been 
considered inoperable (i.e., seizures misinterpreted as arising simultaneously from 
the basal temporal and frontal areas). 
 
6.4  The role of intracranial EEG electrodes in TLE  
 
In the present Study I, 36% (50/140) of the patients underwent invasive preoperative 
EEG-evaluation with subdural strip electrodes in order to confirm the area of seizure 
onset.  According to our agreed upon clinical protocol, none of the patients in Study 
IV who had normal high-field preoperative MRI was operated on without intracranial 
EEG- recording. The role of the ictal EEG findings is emphasized in the preoperative 
work-up when the structural imaging studies do not aid in defining the epileptogenic 
areas. However, the spatial resolution of invasive intracranial EEG in a complex 
three-dimensional cerebral cortex is limited and it may also result in false localisation 
(Eisenschenk et al. 2001, Knowlton et al. 2008). Of 29 patients (Study IV) with even 
unilateral temporal seizure onset, only 13 (45%) patients had good outcome and 16 
(55%) patients had poor outcome. In these patients the surgical failure is probably 
due to insufficient excision of epileptogenic tissue. Patients may have more remote 
areas of epileptogenicity or diffuse epileptogenicity in the residual temporal lobe. A 
satisfactory resection of one epileptogenic region may still result in failure when 
another site, such as the opposite medial temporal area, begins or continues to 
initiate seizures.  
 
After failed initial invasive monitoring, some patients may benefit from re-evaluation 
with intracranial electrodes (Siegel et al. 2000). In Study IV, two patients were re-
evaluated with intracerebral depth electrodes inserted into the hippocampus and 
amygdala. For one of them the site of seizure origin could be identified, and the 
patient became seizure-free. To entitle the patient to a second invasive procedure, 
the practical benefit of such second implantations should certainly be judged to be 
very high. 
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6.5  Strategies for surgical resections in TLE 
 
Classical resection of the anterior temporal lobe, including 
amygdalohippocampectomy, was applied in majority of the patients. Resection of the 
temporal neocortex could have been tailored according to the intraoperative ECoG 
findings, but it never exceeded 3.5 cm on the dominant side and 4.5 cm on the non-
dominant side measured from the tip of the temporal lobe. Since 2001, a more 
sparing neocortical resection was adopted, leaving the upper temporal gyrus intact. 
In Study I, selective amygdalohippocampectomy was performed in 13% of the 
patients and in Study IV in 21% of the patients. In Study IV, the type of resection had 
no impact on seizure outcome regardless of whether a selective 
amygdalohippocampectomy or classical ATL including amygdalohippocampectomy 
was performed. The impact of the resection type was not analysed separately in 
Study I. Most retrospective analyses have concluded that there is no significant 
difference in seizure outcome between more selective and classical ATL types of 
resection (Arruda et al. 1996, Clusmann et al. 2002, Paglioli et al. 2006).  
 
 
6.6  Complications and mortality 
 
In the present study the total rate of major complications related to resective surgery 
was 2% and for minor complications 10%. Our results are in line with the rate of 
complications reported in a large single-centre study in Germany (Behrens et al. 
1997) and a multicentre study in Sweden (Rydenhag and Silander 2001). Behrens et 
al. reported that the total rate of complications causing permanent morbidity was 2%, 
and the Swedish survey reported major complications in 3.3% for all resective 
procedures and 2.8% for temporal lobe resections. In our Finnish series no 
permanent hemiparesis was noted. On the other hand, the present series did not 
include any extratemporal surgery, which probably carries a higher risk for injury of 
the e.g. primary motor cortex and associated descending pathways.      
 
Twenty-five percent of the evaluated patients showed transient complications related 
to intracranial EEG, but for all patients the EEG evaluation could be finished as 
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planned. The overall rate of major complications related to invasive EEG evaluation 
has been reported to be low (Swartz et al. 1996, Behrens et al. 1997, Wiggins et al. 
1999, Rydenhag and Silander 2001, Burneo et al. 2006). This applies especially to 
the subdural strip electrodes, which were used with a majority of the patients in the 
present studies. 
 
In Study I, six patients died during follow-up, of whom four had evidence of poor 
postoperative control of seizures. Sperling et al. evaluated and followed up 
prospectively a cohort of 583 patients who had had epilepsy surgery. They reported 
19 deaths in their series, 18 of which were observed in patients with recurrent 
seizures. They concluded that successful epilepsy surgery reduces the risk of 
epilepsy-associated death (Sperling et al. 2005). Salanova et al. showed that the late 
mortality in 215 operated TLE patients occurred predominantly in patients with 
persistent seizures. In those patients who became seizure free, the mortality rate was 
similar to that of the general population (Salanova et al. 2002).  
 
6.7  Clinical impact 
 
The findings of the present series of studies support the concept that TLE surgery is 
beneficial, especially in MRI-positive patients, but also in selected patients with 
normal MRI. The evolution of MRI techniques and other non-invasive investigations 
will probably reduce the need for invasive EEG-evaluation. This study emphasises 
the importance of a multidisciplinary team in the complex presurgical evaluation of 
candidates for surgery. To maximise the benefit for the patient, epilepsy surgery 
should be performed in centres with multidisciplinary expertise and experience. 
 
 
 
 
 
  63
7  CONCLUSIONS 
 
1.  The postoperative long-term seizure outcome in a Finnish national referral centre 
for epilepsy surgery with adult TLE patients is comparable to reported results from 
established and recognised epilepsy centres worldwide. Outcome at one-year 
postoperatively was predictive of long-term outcome. Surgical treatment was also 
beneficial in a group of palliatively treated TLE patients, who in the preoperative 
evaluation did not have unilateral onset of seizure. 
 
2.  When refractory epilepsy patients with intracranial EEG-electrodes are evaluated, 
the 3-D reconstructed MRI imaging is superior to skull X-ray films for visualising the 
position of the electrodes in relation to the detailed cortical anatomy. This helps to 
delineate the area of seizure onset and helps to plan surgical resection. 
 
3. Preoperative evaluation with intracranial EEG electrodes is safe. Surgical 
complications related to the invasive evaluation were all transient and cause no 
permanent morbidity. Resective surgery in TLE can be performed with an acceptably 
low rate of morbidity, and there was no mortality related directly to the surgical 
procedures. 
 
4. Patients with no focal abnormality in preoperative MRI usually require chronic 
intracranial EEG studies to define the epileptogenic area. Epilepsy surgery is 
beneficial in these MRI-negative TLE patients even though the outcome is not as 
favourable as in patients with focal pathological findings in MRI. MRI findings 
correlate positively with the outcome of TLE surgery. Therefore patients who could 
be candidates for surgical treatment, but who have previously had unremarkable MRI 
scans, should be rescanned and re-evaluated for possible surgery when more 
advanced equipment and methods are available. 
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Temporal lobe epilepsy (TLE) is the 
most frequent type of focal drug-
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